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ABSTRACT 
 
Osteoarthritis (OA) is a complex disease characterized by the destruction of the 
articular cartilage of the joints. The main symptoms are pain and disability, caused 
most probably by secondary synovitis. Secondary manifestations of OA are 
considered to be bone changes, osteophytes, subchondral sclerosis, and bone cysts. 
The suspected risk factors for OA include genetic predisposition, gender (greater in 
females), old age, obesity (also in non-weight-bearing joints), previous injury and 
various physical loading conditions. Prevalence of the disease varies between 
approximately 8 % and 60 %, dependent on the joint, but also largely on the age of 
study subjects, the population and OA definition. The disease affects the cartilage, 
bone, and synovium, but the etiology is still mainly unknown. Even the initiating 
events and tissue are unknown, but mechanical wear and tear is considered as the 
prime candidate for the root cause of the disease.  
 
The role of the genetic component in common skeletal diseases is well established 
but remains poorly understood. Heritability of hand and knee OA in women has 
been shown to range from 39 % to 65 %. Previous association studies have provided 
some evidence for genes affecting bone density, inflammation, composition and 
break down of the extracellular matrix. However, these results have been 
inconsistent.  
 
The objective of the present study was to identify predisposing genes for OA using 
single nucleotide polymorphism (SNP) markers. The study consisted of hand, knee 
and hip OA cases (n = 1466) and controls (n = 4475). A set of 25 candidate genes 
were studied in carefully selected case-control, family and twin settings.   
 
The objective of Study I was to pinpoint an OA-predisposing gene at the 2q11.2 
region, which has previously been linked with hand OA using partially the same 
study sample (Leppävuori et al. 1999). In total 32 SNPs were genotyped in this 
region comprising 6 genes belonging to the interleukin 1 super-family. IL1R1 was 
associated with hand OA (p = 0.00091, with a significance threshold of p = 0.0021). 
 
The aim of Study II was to identify genetic variants in MMP8 and MMP9 genes that 
predispose to OA. Five different study cohorts including 1369 OA cases and 4445 
controls were studied. Evidence for the role of MMP8 in knee OA was observed in 
one study sample (p = 0.0049, with a significance threshold of 0.0057) without 
statistically significant replication. The main association finding was found in the 
 Finnish study sample for knee OA, while a similar tendency was observed in both 
the knee OA study sample of Spanish origin, and the hand OA sample of Finnish 
origin.  
 
The aim of Study III was to identify variants predisposing to hip OA from a 
preselected set of 25 biologically interesting candidate genes. Hips of the study 
subjects had been analyzed using magnetic resonance imaging (MRI). Variants in 
the COL9A2 and COL10A1 genes showed suggestive association (p = 0.0021 and p 
= 0.0015, with significance threshold of 0.00073). The change in the same codon of 
the COL9A2 has previously been shown to associate with a disc degeneration 
phenotype (Videman et al. 2009).  
 
In conclusion, the results of this thesis support the theory that inflammatory factors, 
cartilage breaking factors and originally poor quality of collagen associate with OA.  
Validation of all these results in larger study populations with more accurate genetic 
analysis are still needed for any further conclusions. 
 
Key words: osteoarthritis, gene, association, matrix metalloproteinase 8, interleukin 
1 receptor 1, type IX collagen alpha 2
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TIIVISTELMÄ 
 
Nivelrikko on monitekijäinen nivelruston rappeumasairaus. Sen pääasialliset oireet 
ovat todennäköisesti sekundaarisen synoviitin aiheuttamat kipu ja toiminnalliset 
nivelvaivat. Luunmuutoksia, osteofyyttejä, rustonalaisen luun skleroosia ja kystia 
pidetään sekundaarisina muutoksina. Perintötekijät, naissukupuoli, ikä, lihavuus 
(myös nivelissä, jotka eivät kuormitu painon vuoksi), aiemmat nivelvammat ja 
erilaiset fyysiset kuormitukset ovat nivelrikon riskitekijöitä. Taudin yleisyys 
vaihtelee 8 ja 60 %:n välillä riippuen tutkittavasta nivelestä, ikäryhmästä, väestöstä 
ja nivelrikon määritelmästä. Tauti vaikuttaa rustoon, luuhun ja nivelkalvoon, mutta 
taudin etiologia on vielä tuntematon. Jopa taudin alulle panevia tapahtumia tai 
varhaisia kudosmuutoksia ei vielä tunneta, mutta mekaanista kulutusta pidetään 
yhtenä tärkeimpänä tekijänä taudin synnyssä.  
 
Geneettisten tekijöiden merkitys tuki- ja liikuntaelinsairauksissa on yleisesti 
tunnustettu, mutta huonosti ymmärretty. Geneettiset tekijät selittävät käsi- ja 
polvinivelrikosta 39 - 65 %. Aiemmat assosiaatiotutkimukset ovat osoittaneet luun 
tiheyteen, tulehdukseen, ruston koostumukseen ja hajotukseen liittyvien geenien 
vaikuttavan nivelrikkoon, mutta useat tulokset ovat edelleen ristiriitaisia.  
 
Tämän väitöskirjatyön tavoitteena oli tunnistaa nivelrikolle altistavia geenejä. 
Tutkimus koostui käden, polven ja lonkan nivelrikkoa sairastavista henkilöistä (n = 
1466) sekä näiden verrokkihenkilöistä (n = 4475). Yhteensä 25 ennalta valittua 
ehdokasgeeniä tutkittiin tarkoin valituissa tapaus-verrokki-, perhe- sekä 
kaksosasetelmissa. 
 
Ensimmäisen tutkimuksen tavoitteena oli osoittaa kromosomialueelta 2q11.2 
nivelrikolle altistava geeni. Alueen oli aiemmassa suomalaistutkimuksessa havaittu 
kytkeytyvän käden nivelrikkoon aineistossa, joka oli osittain päällekkäinen tämän 
tutkimuksen aineiston kanssa (Leppävuori et al. 1999). Yhteensä 32 SNPiä (yhden 
emäksen polymorfioita) analysoitiin tältä kuusi interleukiiniperheen geeniä 
sisältävältä alueelta. IL1R1-geenin todettiin assosioituvan käden nivelrikkoon (p = 
0.00091, kun  merkitsevyysraja oli p = 0.0021). 
 
Toisessa tutkimuksessa syvennyttiin matriksi metalloproteinaasi 8 (MMP8) ja 
matriksi metalloproteinaasi 9 (MMP9) -geeneihin polven nivelrikossa. 
Tutkimuksessa käytettiin viittä eri tutkimusaineistoa, jotka sisälsivät 1369 
nivelrikkoa sairastavaa and 4445 tervettä verrokkia. Näiden avulla löydettiin 
assosiaatio MMP8-geeniin (p = 0.0049, kun  merkitsevyysraja oli 0.0057), mutta 
löydös ei toistunut muissa aineistoissa tilastollisesti merkittävällä tasolla. Päälöydös 
 tehtiin suomalaisessa polven nivelrikkoaineistossa, mutta myös suomalainen käden 
nivelrikkoaineisto ja espanjalainen polven nivelrikkoaineisto näyttivät 
samansuuntaista tulosta. 
 
Kolmannen osatyön tavoitteena oli tutkia nivelrikolle altistavia variantteja 25:stä 
biologisen merkityksensä vuoksi ennalta valitusta ehdokasgeenistä. 
Tutkimushenkilöiden lonkkanivelet oli analysoitu magneettisella 
resonanssikuvantamisella (MRI).  Kaksi varianttia, geeneissä kollageeni 9 alfa 2 
(COL9A2)  sekä kollageeni 10 alfa 1 (COL10A1), näyttivät altistavan lonkan 
nivelrikolle (p = 0.0021 and p = 0.0015, kun  merkitsevyysraja oli 0.00073). Tulos 
ei ollut tilastollisesti merkitsevä. Saman kodonin muutoksen COL9A2-geenissä on 
aiemmin todettu altistavan selän välilevyrappeumalle (Videman et al. 2009). 
 
Yhteenvetona voidaan todeta, että tämän väitöskirjatyön tulokset tukevat aiempaa 
teoriaa siitä, että tulehdukselliset ja rustoa hajottavat tekijät sekä jo alun alkaen 
huonolaatuinen kollageeni altistavat nivelrikolle. Nämä tulokset on kuitenkin 
validoitava laajemmissa aineistoissa ja geneettisiä analyysejä on tarkennettava 
varmempien johtopäätösten tekemiseksi. 
 
 
 
Asiasanat: nivelrikko, geeni, assosiaatio, matriksi metalloproteinaasi 8, interleukiini 
1 reseptori 1, tyypin IX kollageeni alfa 2 
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1 INTRODUCTION 
Osteoarthritis (OA) is a degenerative joint disease with pain and disability as the 
main symptoms. The disease is common in the elderly, in fact it is so common that 
there seems to be a tendency towards thinking that aching joints are a part of normal 
aging, which to some extent may be true. However, OA changes in the joints 
represent wear and tear as a pathological process with heritable input. One theory 
behind the disease is that for some reason the cartilage of joints breaks down, and 
that the structural components of the cartilage initiate an auto-inflammatory 
reaction. This leads to a vicious circle of further degradation of the cartilage.  
 
Even today the etiology of OA is mainly unknown. Researchers do not agree over 
where the disease originates; e.g. does it start from the cartilage of joints and 
progress to bone or vice versa. The complexity of the disease, with genetic and 
environmental factors acting together, the lack of knowledge on its etiology, and the 
usually slow disease progression, have made it difficult to develop disease-
modifying medication. Analgetics and anti-inflammatory drugs are the main 
treatment in this disease. A true knowledge of the biological mechanisms behind OA 
is needed for further drug development. 
 
Based on twin studies, it seems that about half of the variation in the occurrence of 
OA is due to genetics and half is caused by environmental factors (Spector et al. 
1996; Neame et al. 2004). Previous genetic studies have concentrated on collagens 
and cartilage matrix degrading factors, since the main visual change in OA is the 
breakdown of joint cartilage. This is composed, to a large extent, of collagens that 
are maintained by cycles of breaking down and repair by chondrocytes, the main cell 
type of cartilage. Lately it has become clearer that cell signalling and inflammation 
additionally play a role in the pathomechanisms. 
 
One reason for this lack of understanding, is that studies of musculoskeletal diseases 
are not as well financed in many countries, as studies of life-threatening diseases. 
However, the societal costs for musculoskeletal diseases are high. In Finland, OA 
causes more than 600,000 doctor visits per year (Häkkinen et al. 2006) with OA 
surgery causing costs of 84 Million $ per year (Remes et al. 2007). Based on earlier 
studies (Mäkelä et al. 1993; Kiiskinen et al. 2005; Kaila-Kangas 2007), Heliövaara 
(2008) estimated the yearly costs of OA in Finland to be about 1000 Million $, 
including the direct costs of hospitalization and indirect costs such as working 
disability. Medical studies of OA are therefore an important investment that could 
decrease the cost this disease causes to society. The final aim of the studies is to stop 
the irreversible destruction of joints, or more importantly prevent the chain of 
Introduction 
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destructive events in the first place. Thus increase the quality of life of the patients, 
by lessening the pain this common disease causes to many of the elderly. 
 
Exercise is one key element to keep the joints and the musculoskeletal system in 
good condition. This also affects the other way around, as functional joints are 
necessary for exercise, which in turn is vital to the prevention of many other 
common conditions, such as obesity, type II diabetes, and cardiovascular disease. A 
study by Nüesch et al. (2011) concluded that OA patients are at higher risk of death 
compared to the general population (standardized mortality ratio after 14 years of 
follow-up 1.55, 95% confidence interval (CI) 1.41 - 1.70). This effect was not due to 
factors like obesity or joint surgery, but the major risk factor for health was walking 
disability combined with the history of diabetes, cancer, or cardiovascular disease. 
 
Lately, increasing knowledge of the human genome, improvements of genotyping 
technologies, and reduced genotyping costs, have made it possible to perform high 
throughput gene mapping studies. It is already possible to sequence the whole 
human genome, and soon such protocol will be achievable in a reasonable cost and 
time frame. Unfortunately, the complexity of many diseases makes it difficult to 
solve the entire underlying genetic background. In many diseases even the largest 
genome-wide studies, with tens of thousands of individuals and well defined family 
samples, have left a large part of the known disease heritability as a mystery. In OA, 
many study samples still wait to be analyzed with the genome-wide platforms, and 
many new causative gene variants are waiting to be found. 
 
The aim of this thesis work was to investigate the role of several candidate genes in 
different types of OA, using twin, family and case-control settings. The study was 
initiated before the understanding of what is now fundamental knowledge. For 
example, the segmented structure of DNA was only detailed later through the 
HapMap project. Additionally, since this field evolves fast, the study designs used 
changed during the study. 
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2 REVIEW OF THE LITERATURE 
2.1 Gene mapping of complex diseases 
2 .1 .1  V ar ia t ion  i n  th e  gen o m e  
Nearly the entire human genome, 3.2x109 base pairs, is similar in all humans. Only 
approximately 0.1 % of it differs between individuals. For the survival of a species 
living in a changing environment, the ability to develop changes in DNA over time 
is essential. Mutations can be advantageous, neutral or disease predisposing. 
Variation such as deletion, insertion, or substitution can occur in a single base pair 
or to larger segments of DNA. A single nucleotide polymorphism (SNP) is a 
sequence variation affecting only one base pair. Microsatellite markers (short 
tandem repeats, short sequence repeat) are repeat sequences of a few bases per 
repeat ([CCA]n), while minisatellites consist of dozens of base pairs, and copy 
number variations (CNVs) up to thousands of base pairs. In the repeat sequences, 
the amounts of repeats can differ between individuals (Lander et al. 2001; Venter et 
al. 2001; The International HapMap Consortium 2005). 
2 .1 .2  H er i tab i l i ty  
Heritability is defined as the proportion of phenotypic variability between 
individuals that is caused by genetic variance. Heritability is dependent on the 
population studied (Kempthorne et al. 1961). A trait with a high heritability, for 
example height, with a heritability of roughly 80 % indicates that 20 % can be 
attributed to environmental factors such as nutrition. (Silventoinen et al. 2003). 
Twins are usually studied for heritability estimates: on average monozygotic twins 
share 100 % and dizygotic twins 50 % of their genome. If both types of twins share 
their environmental factors, the monozygotic twins are more similar than dizygotic 
twins purely due to genetic factors (Kempthorne et al. 1961). 
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2 .1 .3  L in k ag e  d i seq u i l ib r iu m  b e tw een  m ark ers  an d  th e  
H ap M ap  p ro jec t  
Without the shuffling of recombination, all chromosomes would be inherited as a 
whole. Even if the chromosomes are under the mixing force of crossing over, 
markers close to each other are still more likely to be inherited together, and are 
therefore said to be in linkage disequilibrium (LD) with each other. An LD block 
can be considered as a region of low recombination, and the boundaries for these 
blocks have been shown to be similar across populations (Gabriel et al. 2002). The 
HapMap project was launched to determine the LD structure of the human genome. 
The idea was that an LD map of the whole genome would help geneticists to select 
relatively few informative tag SNPs for genotyping. A tag SNP would represent the 
surrounding region that is in high LD with it, and this SNP would therefore be the 
only one that needs to be genotyped in that specific region. All known variants in the 
region need not be genotyped in order to fully capture an LD block. In phase 1 of 
HapMap there were altogether 270 individuals with European, Nigerian, Japanese 
and Chinese backgrounds genotyped. The original goal was to genotype more than 
one million SNPs in these samples (The International HapMap Consortium 2003; 
2005). 
 
The LD blocks harbor different haplotypes, which are allele combinations of SNPs. 
Only about 3 – 5 common (> 5 %) haplotypes explain about 90 % of one LD block. 
Thus, it seems that only about 6 – 8 tag SNPs are needed to identify these different 
common haplotypes in one LD block (Gabriel et al. 2002).  
 
The HapMap tag SNP method has been criticized over its ability to fully cover areas 
studied in the chromosomes. Some SNPs could be missed even when genotyping tag 
markers in high LD with them. Additionally, the LD structure might not be identical 
between case and control groups if one is looking at a functional SNP (Terwilliger et 
al. 2006). 
2 .1 .4  T h e  1000  G en om es  P ro jec t  
The aim of the 1000 Genomes Project, launched in 2008, was to sequence the 
genomes of 2,500 study subjects. Individuals of European, American, East Asian, 
South Asian and West African ancestry have been sequenced as part of the project 
(1000 Genomes, http://www.1000genomes.org/). The purpose is to gain deeper 
understanding of the human genome, especially the LD structure. The idea is to be 
able, in the future, to genotype one set of variants and impute the missing genotypes. 
Some basic information of the genome variation learned so far is that an individual 
differs from the reference sequence by 10,000-11,000 non-synonymous sites and by 
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10,000-12,000 synonymous sites. Each genome is heterozygous for 50-100 variants 
that cause inherited disorders. While new mutations occur in each individual with 
the rate of about 1.0 %10&8 per base pair per generation (The 1000 Genomes Project 
Consortium 2010) 
2 .1 .5  A sso c ia t ion  an a ly s i s  
Association analysis is a statistical test of the co-occurrence of an allele with a 
phenotype. Association is commonly studied in a case-control setting of unrelated 
subjects (Ott et al. 2011). Association analysis is usually performed with SNP 
markers since they are more common than any other variation type. On average, 
there is 1 SNPs per 1 kb in the human genome. SNPs are also favorable markers 
because new mutations are rarer than in the mutation-susceptible repeat sequences 
(The International HapMap Consortium 2003; 2005). In addition to the case-control 
setting association can be studied using the transmission disequilibrium test (TDT). 
This tests if heterozygous parents transmit a certain allele to diseased offspring more 
often than the other allele. However, it uses only heterozygous parental genotypes, 
and it only detects linkage in the presence of population level association (Spielman 
et al. 1993). Additionally, programs that are able to analyze sib-pairs, families, cases 
and controls jointly have been developed. The analysis is more powerful with 
family-based data, and one can utilize all possible samples with a program 
combining different data sets than with programs only utilizing specific family 
structures or only the case-control setting (Hiekkalinna et al. 2011a; Hiekkalinna et 
al. 2011b). Haplotypes can also be used in the association analysis. However in 
haplotype association tests, estimations of the haplotypes have to be made (Ott et al. 
2011). 
2 .1 .6  L in k age  an a ly s i s  
Microsatellite markers have traditionally been used in linkage studies. They are 
more informative than SNPs since there are more alleles in microsatellite markers: 
Microsatellite markers are repeat sequences of different lengths whereas SNPs have 
typically only two alleles. Microsatellite markers are, however, rarer (Chapman et 
al. 1998). In linkage analysis it is possible to test if a chromosomal region co-
segregates with the studied trait. Linkage analysis is based on the calculation of the 
recombination fraction (', theta), which is the proportion of meiotic events in which 
two loci are separated by recombination. Two loci close together are unlikely to 
have been separated from each other by crossing over and their recombination 
fraction is usually close to 0 (complete linkage). Two loci physically far apart are 
more likely to have been separated from each other, and therefore their 
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recombination fraction will be closer to 0.5 (no linkage). The ' can be calculated by 
dividing the number of recombinant progeny by the total number progeny. In 
computerized analysis, the likelihood of the two loci being linked (' = 0) and the 
likelihood that the two loci are not linked (' = 0.5) is calculated. The ratio of these 
likelihoods is called the odds of linkage and its logarithm is called the logarithm of 
odds of linkage (LOD score). The LOD scores are estimated for different values of 
', with the most likely value for ' being the one that gives the highest LOD score. 
When many families are used, the LOD scores of all the families are summed, with 
the LOD scores of 3 and -2 being used as criteria for the presence or exclusion of 
linkage, respectively (Morton 1955; Ott 1991). 
 
Linkage analysis can be non-parametric (model free analysis) or parametric. 
Parametric analysis is a powerful analysis method when the inheritance model of a 
disease is known.  Unfortunately, the inheritance model in complex diseases is often 
unknown (Morton 1955; Ott 1991). 
2 .1 .7  L in k age  v s .  a s soc ia t ion  
Linkage is a phenomenon of long chromosomal range whereas association has 
previously been used in narrowing a linkage finding to a smaller region. All humans 
have common ancestors if we go back far enough in time. Recombination over 
hundreds of years has made the shared chromosomal segments small between two 
randomly selected individuals. Population isolates are widely used in gene mapping 
studies with a common feature to them being their low immigration and emigration. 
Such isolates generally have a distribution over a relatively small area. One example 
of isolate linkage mapping is a type 2 diabetes study in Finnish population sub-
isolate. A variant near the gene MODY3, on chromosome 12q24, was associated 
with the disease (p = 2x10-5) (Mahtani et al. 1996) which has previously been 
associated with early onset monogenic diabetes (Vaxillaire et al. 1995) 
2 .1 .8  G en om e -w id e  s t ra tegy  
Previously in disease mapping, biologically interesting candidate genes were 
selected as study targets. Today, GWA studies with about 600.000 SNP markers 
throughout the genome have become the standard way of performing gene mapping 
studies. Exome sequencing and whole-genome sequencing are now becoming more 
common. Many genome-wide studies have revealed remarkable results, such as 
finding of previously unknown gene loci for type 2 diabetes (Saxena et al. 2007; 
Sladek et al. 2007; Steinthorsdottir et al. 2007) discussed in the following chapter, 
since no prior knowledge of disease traits is needed opposite to candidate gene 
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studies. But then again for example, too sparse marker maps are one reason for 
failure in whole genome-wide studies. 
 
 
Genome-wide linkage 
 
Traditionally, genome-wide linkage analysis has been used to find susceptibility loci 
for disease. A few hundred microsatellite markers throughout the human genome are 
chosen, with a spacing of approximately 10 mega bases (Mb). This should cover 
approximately 50 % of the genetic variance in the genome when assuming that the 
used markers have a heterozygocity of 75 % (Kruglyak 1997). For population-based 
association studies the microsatellite marker maps are too sparse. Half of the LD 
blocks are shown to be 22 kb in length or larger in African and African-American 
populations, and 44 kb or larger in European populations. Thus only about 1 % of 
the genome would be covered in population-based studies with the microsatellite 
markers (Gabriel et al. 2002). Since the linked regions are usually large, familial 
genome-wide linkage analysis is often followed by fine-mapping and candidate gene 
studies in which biologically relevant genes from the linked regions are selected for 
denser mapping, as in the study by Leppävuori et al. (1999) and Study I of this 
thesis.  
 
 
Genome-wide association 
 
Improved technologies and statistical analysis methods, combined with decreased 
costs, have made it possible to conduct extensive genome-wide association (GWA) 
studies. Illumina, Inc. (2009) sells GWA chips covering over 1.1 million variants 
including CNVs. Whilst, Affymetrix, Inc. (2009) have a similar product with 1.8 
million markers. 
 
One well known success story of GWA is type 2 diabetes. In these studies, the types 
of genes found and confirmed to affect the disease would not have otherwise been 
studied, such as the “solute carrier family 30 (zinc transporter), member 8” gene 
(SLC30A8) (p = 6x10-8) (Saxena et al. 2007; Sladek et al. 2007) and the “CDK5 
regulatory subunit associated protein 1-like 1”  gene (CDKAL1) (p = 4.1%10&11, p = 
7.7x10-9) (Saxena et al. 2007; Steinthorsdottir et al. 2007). 
 
It is accepted that disease predisposing variants found from case-control GWA 
studies have only low odds ratios for the studied trait, as was the case in the diabetes 
GWA findings. However, one could still argue that they provide important 
knowledge of disease etiology. Opponents claim that since the idea of the GWA is 
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based on the tag SNP method, the genome will not be fully covered and much will 
be missed in these studies (Terwilliger et al. 2006). 
 
In conclusion, with hundreds of thousands of SNPs analyzed throughout the 
genome, no assumptions need to be made concerning the genomic location of causal 
variants, giving this method a major advantage over the candidate gene approach. 
 
 
Whole-genome and exome sequencing 
 
As part of the 1000 Genomes project (The 1000 Genomes Project Consortium 2011) 
whole-genome sequencing in complex diseases will reveal the entire base content of 
the human genome for the study subjects. The goal will then become the 
understanding of the role of the variants in humans, how they function in expression 
modification or even protein structure, which will be achieved with the help of other 
disciplines. As in other genotyping methods, sequence data quality and genome 
coverage are still challenges to be solved. 
 
Today, exome-sequencing is in use for disease-mapping. As a proof-of-concept, Ng 
et al. (2009) sequenced four individuals suffering from a rare monogenic disease 
with a known causative gene (Freeman-Sheldon syndrome (FSS)) and eight 
HapMap individuals originating from three different population backgrounds as 
controls. The causative variant was found when the authors excluded all variants 
seen in the healthy individuals either in the study itself or in pre-existing SNP data 
bases. Only those genes in which all the affected individuals harbored a base 
mutation, either as an amino acid-changing or affecting exon-splicing, were 
included, but not necessarily the same variant in all cases. 
 
Currently, the cost of sequencing one genome is $ 10,000 but it is expected to 
decrease to 10 % of the current cost in the near future (Patterson 2011). Private 
companies already sell exome-sequencing to consumers for less than $1000 
(23andMe, Inc. Mountain View, CA, USA). 
2 .1 .9  C h a l l en g es  in  g en e  m ap p in g  
A positive finding could indicate a true biologically meaningful discovery, e.g. that 
a disease-causing or predisposing variant has been identified. However, a positive 
finding could be caused by other factors as well. A variant in high LD with the 
predisposing one might have been found or the finding could have been made by 
chance. Similarly, although a negative finding can be caused by lack of relevance of 
the gene to the studied trait it can also be observed due to factors relating to the 
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research frame, such as a statistically low-powered study, or phenotypic or 
genotypic heterogeneity.  
 
 
Population stratification 
 
One of the challenges is population stratification, which occurs when the study 
population contains genetically different subsets. For example, if controls are 
selected from Northern Finland and the cases from Southern Finland, the difference 
in allele frequencies between cases and controls could be due to normal genetic 
difference between people from different areas of Finland, and not due to the 
differing disease status between the people studied (Jakkula et al. 2008). The 
situation may also be problematic if individuals are closely related since the basic (2 
association test assumes individuals to be unrelated (Ott 1991). 
 
 
Multiple testing 
 
Type 1 error is typically caused by performing large number of tests, thus increasing 
the probability of discovering positive results by chance. A Bonferroni correction for 
multiple testing is the most common and conservative method to account for the 
number of tests performed. However, the studied gene variants are most often in 
high LD with each other, and therefore the tests performed with these markers are 
not independent, as is assumed by the Bonferroni correction. The LD between the 
markers reduces the number of truly independent tests. One method that takes this 
LD into consideration is the SNP Spectral Decomposition (SpD) method used also 
in this thesis work (Nyholt 2004; Li et al. 2005). Nowadays, a p-value threshold for 
genome-wide significance is considered to be p < 5x10-8, which equals a Bonferroni 
correction for one million tests. 
 
 
Replications 
 
One of the most important aspects of genetic findings is their reproducibility in other 
samples and other populations. In the case of familial mutations, such replication in 
another population will not be possible. However, for common disease-predisposing 
findings replication is the best way to validate the finding. This was the case in 
studies of type 2 diabetes, for example the finding in SLC30A8 was replicated, 
which confirmed that the finding is real and not caused by chance after multiple tests 
or population stratification (Saxena et al. 2007; Sladek et al. 2007).  
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Power 
 
The power to detect an association depends on the methods used, the type of 
markers, population history, the age of the mutation, the sample size, mode of 
inheritance, and the phenotypic heterogeneity of the study sample (Chapman et al. 
1998). According to the GWA study by The Wellcome Trust Case Control 
Consortium (2007) of seven common diseases in 14,000 cases and 3,000 shared 
controls, the odds ratios (OR) usually seen in common variants predisposing to 
complex diseases are between 1.2 - 1.5. This means that large sample sizes are 
needed to detect any effect and thus in many cases a negative finding does not 
exclude the role of a variant for a disease.  
 
 
Gene coverage 
 
When studying candidate genes, it is important to take into consideration how well 
all the genetic variance in a gene region is caught by the SNP panel genotyped. Even 
with statistically powerful sample sizes, negative findings cannot exclude the role of 
a gene if only a portion of the gene has been studied. The HapMap genotyping 
database is one tool for selecting tag SNPs for both candidate gene studies, as 
discussed earlier, (The International HapMap Consortium et al. 2003) and for GWA 
platforms. However, this has been criticized, since disease causing SNPs could be 
missed when only genotyping a tag marker in high LD with it (Terwilliger et al. 
2006). This matter might be solved soon when whole-genome sequencing becomes 
more common. 
 
 
Phenotyping 
 
Besides careful planning of genotyping, one important aspect when planning, or 
interpreting, a study is the phenotyping. In many cases the studied trait is 
quantitative. Height is a good example of such a phenotype,  and with a heritability 
of 80 % (Silventoinen et al. 2003) GWA studies have revealed several pathways 
affecting the trait, including genes in extracellular matrix and cancer traits (p <  
5x10-5) (Weedon et al. 2008). Many complex diseases are spectrums of quantitative 
traits (Figure 1). When dividing a population into cases and controls, one cut-off 
makes some of the cases to be phenotypically close to controls, as shown in part “a” 
of Figure 1. This would be the case if height phenotype would be divided into two 
groups: short and non-short. For rare diseases the use of population controls does not 
seem to prevent the association finding, as was stated by the The Wellcome Trust 
Case Control Consortium (2007). 
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Figure 1. Many quantitative traits are dichotomized in genetic studies. a) A cut-off 
between cases and controls lowers the statistical power. b) When selecting extreme 
phenotypes, the sample set can be used for only one study. c) Study of quantitative traits 
has statistically more power than dichotomous traits and one study sample can be used 
for studies of different phenotypes. Adapted by permission from Macmillan Publishers 
Ltd: Nature Reviews Genetics copyright 2009 (Plomin et al. 2009). 
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When using quantitative measurements, the phenotype will correspond to biology as 
closely as possible, and therefore the power to detect, for example linkage, has been 
shown to be superior when compared to dichotomized traits (Duggirala et al. 1997). 
With a population-based sample of quantitative traits, one can use the same cohort 
for studies of different phenotypes, which can point to a network of related 
quantitative traits. 
 
Based on the discussed studies on phenotyping, it is obvious that there is a need for 
quantitative phenotyping in OA. In OA, the diagnosis is made by a clinician and is 
therefore qualitative, since the diagnosis is usually made in order to assess the 
patient’s need for pain medication, surgery, sick leave etc. Biologically this cut-off 
is not always justified and creates a bias within the study. The disease is more of a 
progress from mild to a possibly severe stage of OA, including different tissues and 
different biological events during the progression, discussed later. 
 
 
Common and rare variants behind diseases 
 
Usually the genetic models behind diseases are unknown. A hot topic discussed in 
gene mapping is whether common variants, that probably only have small effect 
sizes, or rare variants with larger effect sizes should be studied (Figure 2). 
 
In the case of severe, heritable, early-onset diseases, common predisposing variants 
should not even exist due to evolutionary selection, unless there has been recent 
strong environmental changes predisposing to the disease. As OA is a late onset 
disease linked with the immune system, it could be possible that variants 
predisposing to OA today have been and still are useful, for example in microbial 
resistance or in bone health, and have thus become common.  
 
One way of looking at the issue is to ask, which way is statistically, technically and 
financially possible and smart. As discussed previously, in the recent GWA studies 
performed, most of the common disease susceptibility variants found have only had 
a small effect on the disease, thus large study samples have been needed. Whereas, 
variants of low frequency and small effect sizes will not be detectable by population 
association studies, since only a handful of people will carry the disease 
predisposing variants. Detecting these rare variants in families is also difficult, since 
only some of the family members will be affected, even if carrying the rare allele. 
Finding common disease predisposing variants is dependent on high-throughput 
genotyping of large sample sets. Finding rare variants requires sequencing of a large 
number of carefully chosen cases followed by functional studies on the identified 
candidate variants. This kind of study approach has been shown to work even with a 
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handful of samples, when the studied trait is severe enough not to be expected to be 
seen in a population (Ng et al. 2009). 
 
 
 
Figure 2. Effect size vs. allele frequency. Brown color: Common variants are shown to 
have low effect in complex diseases (Wellcome Trust Case Control Consortium 2007). 
Blue color: Rare alleles have been shown to cause Mendelian disorders such as the 
“RNA export mediator homolog (yeast)” gene (GLE1) causing lethal congenital 
contracture syndrome 1 (Nousiainen et al. 2008). Adapted by permission from 
Macmillan Publishers Ltd: Nature (Manolio et al. 2009) copyright 2009; Original image 
by McCarthy et al. (2008). Adapted by permission from Macmillan Publishers Ltd: 
Nature Reviews Genetics, copyright 2008. 
 
 
More importantly we should be asking, which way is biologically sensible to look 
for variants predisposing to common complex diseases. Based on the initial 1000 
Genomes data (The 1000 Genomes Project Consortium 2010), it was concluded that 
a maximum third of complex trait associations are likely to be caused by common 
coding variation. Whilst the majority of the contribution of common variants in 
complex diseases is assumed to be regulatory in nature. Moreover, based on a recent 
study by Zhu et al. (2011) comparing the phenotypic effect of rare and common 
alleles, it seems that rare variants are more likely to be functional than the common 
ones. If an allele had a frequency of more than 10 % it was less likely to be located 
in functional genomic regions, compared to alleles with a frequency of less than 10 
%. However, this phenomenon was only seen in the common situation where the 
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major allele is the ancestral allele and the minor allele is the derived allele. The 
authors concluded that variants that should be enriched for positive selection are 
actually common through genetic drift, not through positive selection. The main 
selective pressure is purifying selection and the main part of the functional variation 
in our genome is caused by mutation-selection balance. 
 
These findings might lead the geneticists back to studying large families and isolates 
in which the disease predisposing alleles are more likely shared between 
phenotypically similar individuals, as opposed to population based cohorts.   
 
 
Missing heritability 
 
Recently, a lot has been discussed about missing heritability. This refers to the issue 
that so far in studies of complex diseases, even the most extensive GWA studies in 
several large population have only been able to explain a small proportion of the 
heritability that have been discovered through twin studies (Wellcome Trust Case 
Control Consortium 2007). Thus rare, as yet unstudied, variants, rare Mendelian 
traits and well-genotyped families are promising candidates for future studies. All in 
all, it seems that different approaches are needed in order to solve the entire genetic 
background of complex diseases.  
 
 
The complex nature of the challenges 
 
There is a cross-link between the challenges of power and selecting a study 
population. When increasing the sample size for statistical power, one might also 
increase the allelic and phenotypic heterogeneity. As described by Terwilliger and 
Weiss (1998): “If there is substantial allelic heterogeneity then as one increases the 
sample size, the number of different disease-predisposing alleles (each with their 
own independent haplotype of nearby marker alleles) may likewise increase, and 
thus there may never be much power even with complete ascertainment of the entire 
human population.” (Reprinted with permission from Elsevier Ltd, Copyright 1998). 
 
Another cross-link is between power, in terms of selecting common enough 
markers, and the biological background of complex diseases. Common SNP markers 
have not fully explained the familiality of many diseases, which could mean that the 
rare variants play the major role in many diseases (Wellcome Trust Case Control 
Consortium 2007). If this turns out to be the case, most of the meaningful markers 
have been selected out of GWA studies in order to gain statistical power. 
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The reality probably lies somewhere between these scenarios: GWA studies in large 
cohorts with many different traits have shown that there are common alleles that can 
be found, and some of the findings would not have been done if we only proceeded 
in an hypothesis based manner (Saxena et al. 2007; Sladek et al. 2007; 
Steinthorsdottir et al. 2007; Wellcome Trust Case Control Consortium 2007). 
 
Population sub-isolates will probably be the way to go during the next decade, since 
in isolates the genetic heterogeneity is smaller and thus it is likely that individuals 
with similar outcome share the same potentially rare genetic factors.  
2.2 Osteoarthritis 
OA is a degenerative joint disease common in the elderly. The disease affects the 
bone, cartilage and synovium (Figure 3).  
 
 
Figure 3. Normal joint and joint with osteoarthritic changes (Free ClipArt 2009). The 
OA joint suffers from a loss of cartilage, bone changes, osteophytes, subchondral 
sclerosis and bone cysts. Synovitis, joint space narrowing and subchondral bone 
sclerosis are erroneously not shown in the figure. http://cksinfo.com/medicine/page2.html. 
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The etiology of the disease is, even today, not understood, but it is supposed that 
some unknown genetic factors play a role in its development. What is also known, is 
that OA can develop in an anatomically normal joint (primary OA), or in a joint 
suffering from injury, some other disease, or developmental defect such as 
congenital dislocation of the joint (secondary OA) (Pearson et al. 1962).  
 
Autoimmune factors also play a role, linking the disease to other inflammatory 
diseases such as rheumatoid arthritis (RA). The heritability of radiographic hand and 
knee OA has been estimated to range between 39 % and 65 % (Spector et al. 1996; 
Neame et al. 2004). 
2 .2 .1  S ym p tom s  
Based on the criteria set by The American College of Rheumatology, pain, aching, 
and stiffness are the main symptoms of OA. Stiffness in the morning might occur for 
30 minutes and there might be a mild inflammatory swelling. In rheumatoid arthritis 
the symptoms resemble OA, but for instance, the swelling and morning stiffness are 
more severe and last longer in RA (Altman et al. 1990; Altman et al. 1991; 
Kawasaki et al. 1998). 
2 .2 .2  K el lgren  an d  L aw ren ce  c la s s i f i ca t ion  
Diagnostics for OA have been discussed for a long time. Radiological classification 
of OA was invented by Kellgren and Lawrance (1957), and has been widely used 
ever since. The grading is between 0 and 4; 0 corresponding to a healthy joint and 4 
corresponding to severe OA. The grading is based on visual x-ray observations of: 
ostophytes which could be described as formation of bony nodules; periarticular 
ossicles which are bone formations in an abnormal area of the joint; narrowing of 
the joint cartilage associated with sclerosis of the subchondral bone; small cystic 
areas with sclerotic wall situated usually in the subchondral bone; and altered shape 
of bone.  
 
The controversy surrounding this classification is the relationship between the 
symptoms and the radiological assessment of this disease. The radiological changes 
are more common than the symptoms (see next chapter). The radiological changes 
predispose to the symptoms in the same joint. However, most people with the 
radiological changes do not have symptoms, such as pain and stiffness, at all. 
Moreover, patients suffering from pain in their spine can be totally normal in 
radiological grading (Lawrence et al. 1966).  
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2 .2 .3  H er i tab i l i ty  an d  p reva len ce  
MacGregor et al. (2000) reported heritability of radiographic hip OA to be 58 - 64 % 
in a UK population cohort of women. Zhai et al. (2007) estimated the heritability of 
radiological knee OA to be 69 - 80 % in a population-based study with twins in the 
UK. Similar heritability estimates, made based on radiological hand OA 
examinations in UK women, ranged between 48 - 67 % for radiological phenotype 
(Livshits et al. 2007). 
 
The prevalence of the most common OA types vary approximately between 6 % 
(Zhang et al. 2001) and 48 % (Haara et al. 2003) depending mostly on the joint, but 
also largely on the age of the study subjects, the population, and definition of OA. 
 
Hand and knee OA are common whilst hip OA is rare. The prevalence of 
radiological hand OA was 44 – 48 % in the Finnish population over the age of 30 
years (Haara et al. 2003), and 27 % for radiological knee OA in a study of subjects 
under the age of 70 years (Felson et al. 1987). However, the prevalence of 
radiologic hip OA was 8 %, when standardized for age and sex in an Icelandic 
population over 35 years of age (Ingvarsson et al. 1999). 
 
Women tend to have more OA compared to men. For symptomatic knee OA the 
prevalence was 6 % in men and 15 % in women (Zhang et al. 2001). In the case of 
hip OA there seems to be little or no difference between the genders, being 12 % for 
men and 10 % for women, in the Icelandic study (Ingvarsson et al. 1999). 
 
Symptomatic OA is rarer than radiographic. The prevalence of radiographic knee 
OA in a population aged 60 years or over, was 22 - 43 %, whilst for symptomatic 
knee OA the prevalence was 6 - 15 % (Zhang et al. 2001). 
 
Age is a significant factor. The prevalence of radiological hip OA being 2 % among 
individuals between the ages of 35-39 years and 35 % among individuals over the 
age of 85 years (Ingvarsson et al. 1999). 
2 .2 .4  R isk  fac tors  p red i sp os in g  to  o s t eoar th r i t i s  
The most common known risk factors for OA are genetics factors, female sex, 
obesity, hard physical work, excessive repetitive motions, and previous joint trauma 
(Haara et al. 2003; Recnik et al. 2008). 
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Age and sex 
 
Knee and hand OA prevalence is usually somewhat higher in females than in males 
(Zhang et al. 2001; Haara et al. 2003; Toivanen et al. 2010), which means that being 
female is a risk factor for OA. In a study by Toivanen et al. (2010), the odds ratio 
(OR) for OA in females was 1.7 (95 % confidence interval (CI) 1.0 - 3.1). OA is 
more common in older age groups than younger, with, for example, the OR for older 
age in hand OA being 1.8 (95 % CI 1.4 - 2.3) in the same study. 
 
 
Obesity 
 
One factor predisposing to OA is obesity. The role of obesity in non-weight bearing 
joints suggests a theory that systemic level pathways are playing a role in the 
disease. Muthuri et al. (2011) conducted a meta-analysis of 47 studies using 446,219 
individuals originating from USA, Europe, Australia, North Africa, China, and 
Thailand, which are not individually discussed in the present thesis work. Obesity 
predisposed to knee OA with an overall odds ratio (OR) of 3.91 (95 % confidence 
interval (CI) 3.32 - 4.56), with all individual studies showing the same trend. 
 
Furthermore, not only does obesity predispose to OA in weight bearing joints, but it 
also affects OA in non weight bearing joints, like the joints of the hands (Bagge et 
al. 1991; Cicuttini et al. 1996; Haara et al. 2003). A BMI of more than 35 kg/m2 
doubles the risk of hand OA, compaired to people with normal BMI (20.0 - 24.9 
kg/m2) (Haara et al. 2003). The prevalence of hand OA was found to especially 
increase in the presence of obesity, hypertension, and diabetes, mostly during 
younger age, in a cross-sectional study of a population based on 3585 individuals 
over the age of 55 years (Dahaghin et al. 2007). Additionally, it seems that the 
expression and protein levels of leptin produced by osteoblasts are increased in OA 
(Mutabaruka et al. 2010).  
 
 
Physical loading 
 
High work-related physical loading seems to have a negative effect on hand OA in 
women (Haara et al. 2003). Further, higher measured grip strength has been shown 
to predispose to PIP, MCP, and thumb base joint OA in men (Chaisson et al. 1999). 
It has even been shown that paralysis of hands protects from hand OA (Segal et al. 
1998).  
 
Similarly, many other studies show the unfavorable effect of too heavy loading in 
different joints. A study by Recnik et al. (2008) showed that an unfavorable 
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biomechanical constitution of the pelvis was associated with hip arthroplasty at 
younger age. While Toivanen et al. (2010) showed that the OR for knee OA, among 
individuals that are under heavy physical stress in their work, was 18.3 (95% CI 4.2 
- 79.4), compared to the lightest physical stress category. 
 
 
Traumatic injuries 
 
Previous physical joint trauma is a well-known risk factor for OA. In the study by 
Toivanen et al. (2010) using the Mini-Finland Health Survey with Finnish 
participants, the odds ratio for knee OA was 5.1 (95 % CI 1.4 - 19.0) for previous 
knee trauma compared to a group without trauma. The part of the study examining 
the knee trauma was based on simple yes or no questionnaire. 
2 .2 .5  Jo in t  an d  car t i l age  
In a synovial joint, both endings of the two bones are covered with cartilage, which 
moderates the effect of weight and impact bearing on the bones. The cartilage 
neither contains nerves nor blood or lymphatic vessels, consisting mostly of 
extracellular matrix (ECM). ECM is both generated and broken down by the 
chondrocytes that constitute 1 – 10 % of the cartilage volume. The area around 
chondrocytes can be divided into different structural components of proteoglycans, 
link proteins, and hyaluronic acid (hyaluronan, HA). The matrix is formed by 
proteoglycans, collagens, and water (Huber et al. 2000). Due to the avascular nature 
of the cartilage, the chondrocytes change their metabolites with the surrounding 
system through diffusion to and from synovial fluid. Some of the deeper areas can 
also get nutrients from the subchondral bone (Arkill et al. 2008). 
 
Proteoglycans and collagens are responsible for the elasticity of the cartilage. 
Collagens form a net, which counteracts the swelling pressure of a gel formed by 
water and proteoglycans (Figure 4). Type II collagen is the most abundant collagen 
in cartilage, but other types of collagens, such as type IX, participate by stabilizing 
the net (Huber et al. 2000).  
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Figure 4. Type II collagen in different zones of articular cartilage and the 
organization of type II collagen, proteoglycans and chondrocytes in more detail. The 
collagen net can be divided into three zones, where the uppermost tangential zone has a 
horizontal collagen fiber orientation. The transitional zone has more mixed and the 
radial zone contains mostly vertical collagen fibers. The deepest part of the radial zone 
is formed by calcified cartilage (Huber et al. 2000). Figure adapted from Knee joint 
surgery, www.kneejointsurgery.com/html/articular_cartilage/anatomy.html. 
 
 
Proteoglycans are formed when glycosaminoglycan chains attached to a protein 
core. Aggrecans are the most abundant proteoglycans and they can bind to HA in 
part via a link protein (Figure 5) (Heinegård et al. 2011). Aggrecans are rich in 
chondroitin sulfate and keratin sulfate, which comprise both sulfate and carboxyl 
residues. These residues cause high negative charge density, called the fixed charge 
density, in the ECM. This negative charge attracts positive mobile Na+ ions that 
cause osmotic swelling pressure, and therefore draws water into the ECM. During 
loading, this balance is shifted, and some water is compressed out of the cartilage 
until a new balance is reached. When loading stops, the original balance is reached 
again as the water is absorbed back reinstalling the original water content. The 
ability of the cartilage to resist pressure is a complex system, which additionally 
includes characteristics such as electrostatic repulsion forces of the negative 
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residues, and friction between water and the ECM (Lai et al. 1991; Lu et al. 2008; 
Wang et al. 2008; Han et al. 2011).  
 
 
 
Figure 5. The different cartilage molecules and chondocyte. Many non-collagenous 
proteins in cartilage attach, for example chondrocytes to collagen fibrils. Aggrecan is 
attached to hyaluronan via a link protein. Asporin, decorin, matrilins and cartilage 
oligomeric matrix protein are non-collagenous structural molecules of the cartilage 
(Heinegård et al. 2011). Adapted by permission from Macmillan Publishers Ltd: Nature 
Reviews Rheumatology copyright 2011. 
 
 
Joint space is filled with synovial fluid. This decreases the friction between the 
moving bones, brings nutrients and oxygen to the cartilage, and transports metabolic 
waste away from the cartilage. Normally, the amount of synovial fluid in the knee 
joint is approximately 0.5 - 4.0 ml, under a pressure that is lower than normal 
atmospheric pressure (Kraus et al. 2007). Synovial fluid is produced from plasma by 
synoviocytes (fibroblast-like type B lining cells) (Wilkinson et al. 1992). 
 
This joint structure is surrounded by both a joint capsule, which consists of an inner 
synovium containing blood vessels, lymphatics and nerves, and an outer fibrous 
lining and sub-lining membrane. These are then in turn enforced by ligaments and 
tendons that support the joint in its movements (Huber et al. 2000). 
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2 .2 .6  O steoar th r i t i c  ch an ges  in  th e  jo in t  
Originally, OA was simply considered to represent a disease of mechanical joint 
wear, but nowadays it is known that an additonal complex molecular mechanism 
plays a role. According to one theory, OA represents an imbalance in the 
regenerative and degenerative processes of the cartilage. Nonetheless, even today it 
is not known if the disease starts from the cartilage and progresses to the bones, and 
other parts of the joint, or if this process occurs the reverse direction. Changes are 
seen in cartilage, bone, synovium and muscle as well as in motor programs and 
proprioception. 
 
 
Cartilage 
 
One basic feature of the disease progression is breakage of the cartilage ECM. 
Chodrocytes, are supposed to, at least in part, repair the damaged cartilage by first 
breaking down the damaged area, in order to subsequently repair it. At this point the 
cartilage might get thicker. In later stages, the repairing activity slows down and the 
volume of the cartilage decreases. The surfaces lose their smoothness, become 
fibrillated and fissures are formed. The factors that are breaking down the cartilage, 
e.g. collagenases, aggrecanases and other hydrolytic enzymes, are activated by 
cytokines, growth factors, inflammatory factors or mechanical factors. There are 
also factors inhibiting this breakdown. In OA, the subchondral bones of the bone 
endings get thicker, which might be caused by microfactures, due to excessive 
motion. The activity of bone forming cells called osteoblasts increases bone 
thickness. Resorption of bone tissue and the formation of cysts are seen. 
Additionally, reformation of the bone occurs as the result of ostephyte formation 
(Samuels et al. 2008; Martel-Pelletier et al. 2010). 
 
Cartilage changes have been shown to be the initiating event in joint degeneration 
(Bennett et al. 1942). This finding has been later strengthened by, among others, 
Watters et al. (2007) who reported that mild cartilage damage precedes osteophyte 
development in the STR/Ort murine model. Meachim et al. (1965) concluded that 
the superficial layer of human articular cartilage is affected in aging, in a study 
performed using light microscopy. They showed that degenerative changes can 
occur in areas without fibrillation, changes described as fraying of the cartilage into 
long strands, causing lesions. They suggested that the other degenerative changes of 
the matrix precede the fibrillative changes. Later, among others, Kääb et al. (2003) 
showed, using rabbit knee joints, that the chondrocytes of the superficial layer are 
more affected than chondrocytes of the deeper layers, since their shape seems to 
change more under loading than the shape of the cells in deeper layers. Similarly, 
Chen et al. (2003) showed that the chondrocytes in the superficial layers of bovine 
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cartilage are in higher risk to die through necrosis than the ones in deeper zones, 
when predisposed to pressure. Type II collagen was degraded only in the superficial 
layer due to the loading and collagenase activity. Hollander et al. (1995) showed, 
similarly, in human articular cartilage samples that damage to the key component in 
articular cartilage, type II collagen, in aging and in OA joints occurs first in the 
upper mid zone, proceeding to the lower mid and deep zones with increasing 
degeneration, always starting around chondrocytes. 
 
According to Lorenzo et al. (2004), cartilage goes through metabolic changes in 
very early stages of OA. The levels of non-collagenous molecules, like oligomeric 
matrix protein (COMP), fibronectin, and cartilage intermediate layer protein (CILP), 
were increased in cartilage during early OA when compared to both normal and late 
OA cartilage. 
 
These findings suggest that the cartilage is affected first, with the bone changes 
occuring as a secondary phenomenon. However, larger systematic, proteomic, and 
expression studies at the molecular level are needed to confirm this hypothesis. 
 
 
Inflammation and immune response 
 
Originally, inflammation was thought to be a symptom of other joint diseases like 
RA. Today it is known that inflammation in synovial membranes is an important 
part of OA, even in moderate or mild disease stages. C-reactive protein (CRP) is 
slightly increased in knee OA patients (Spector et al. 1997). In patients undergoing 
joint replacement surgery, the inflammation occasionally even reaches the same 
level as in RA patients (Smith et al. 1997; Haywood et al. 2003). Inflammation 
probably also explains the discrepancy between symptoms and radiological findings. 
 
Inflammation in the osteoarthritic synovium is associated with the production of 
proinflammatory cytokines, such as interleukin 1 alpha (IL-1!), interleukin 1 beta 
(IL-1"), and tumor necrosis factor (TNF-!) (Smith et al. 1997), and with the 
angiogenic growth factor called vascular endothelial growth factor (VEGF) 
(Haywood et al. 2003). 
 
One promising theory connecting inflammation, cartilage breakdown and OA, is that 
the cartilage breakdown products might trigger auto-immune or auto-inflammatory 
reaction that further enhances the cartilage breakdown. Fibromodulin and other 
small leucine-rich proteoglycan (SLRP) family members can initiate the 
complement pathway (Sjöberg et al. 2005; Sjöberg et al. 2009). Many ECM proteins 
have been shown to act as antigens and form an immune complex (IC) with IgG in 
OA and RA joints, with their amount correlating with disease severity. Thus it is 
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possible that the mechanical factors that damage ECM result in a proinflammatory 
reaction (Monach et al. 2009). Moreover, it seems that damaged ECM fragments 
can trigger inflammatory responses by acting as ligands for Toll-like receptors 
(TLR) found in chondrocytes. Chondrocytes can, potentially, produce 
proinflammatory and algogenic molecules, thus they might be the initial source of 
factors responsible for the secondary inflammatory reaction and pain in the 
synovium (Konttinen et al. 2012). 
 
COMP, found in OA and RA synovial fluid, and suggested to be an OA biomarker 
(Saxne et al. 1992), can initiate the alternative complement pathway (Happonen et 
al. 2010). A recent extensive study by Wang et al. (2011) confirmed the role of 
complement in OA. The gene expression and protein levels of complement proteins 
were higher in OA than in both normal synovial fluid and synovium. One 
complement member, membrane attack complex (MAC), was detected in the 
synovium and around chondrocytes of end-stage OA joints. Knockout mice deficient 
for C5 and C6 complement members were less prone to develop OA than controls. 
While knockout mice deficient for complement inhibitor CD59a were more prone to 
develop the disease. The complement cascade either ends up killing the 
chondrocytes or stimulates the cells to produce inflammatory and matrix-degrading 
enzymes (Wang et al. 2011). 
 
To conclude, inflammation seems to be an essential element in OA. The 
complement pathway might be one of the key elements and the TLR-equipped 
chondrocytes might be the initiating cell-type in this process. 
 
 
Obesity 
 
Obesity is a significant risk factor for all OA types, with inflammation a part of the 
disease. Adipokines are one of the key regulators in OA (Koskinen et al. 2011). 
Interestingly, the STR/Ort mice that naturally develop OA, also have high serum 
total cholesterol, high serum triglyceride, hyperinsulinemia, insulin resistance, and 
low serum adiponectin (Uchida et al. 2009). 
 
 
Bone 
 
During progression of OA the shape of the bone ending starts to change, and bone 
marrow lesions appear. These are increased by physical loading and are associated 
with OA pain (Bennell et al. 2010a). Current knowledge cannot exclude the role of 
bone as the initiating tissue in OA. If there were any alterations in the bone endings, 
this would lead to increased pressure and stress in the corresponding area of the 
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cartilage. There is some evidence that osteoporosis (OP) might protect from OA, but 
opposing evidence has also been published, with disussicon about the relation of the 
two traits ongoing (Rechtman et al. 1954; Mäkinen et al. 2007).  
 
 
Chondrocytes 
 
Chondrocytes and their progenitors are the only cell types in cartilage, thus they are 
the main cellular elements that maintain the cartilage. Whatever it is that happens in 
cartilage in OA, it might be initiated by these cells, as mentioned earlier. 
 
Normal adult chondrocytes are not metabolically very active. In OA these cells go 
through maturation and express type X collagen. Endochondral ossification of 
growth plate chondrocytes during development resembles the maturation process of 
chondrocytes in OA. During this stage, chondrocytes proliferate and develop 
hypertrophy, and express type X collagen, which is typical in bone formation 
(Aigner et al. 1993). In OA, the cartilage ECM is being remodeled and mineralized, 
and blood vessels from the subchondral bone invade the cartilage (Bohr 1976), all of 
which are normal phenomenon in bone formation. In normal cartilage aging, the 
amount of chondrocytes decreases due to the lack of new chondrocytes and the 
cartilage becomes more fragile. The cells are not anchored as tightly as before to the 
ECM, and the amount of nutrients is decreased. The rate of maturation slows down 
and cytokines that are typical enhancers of OA are produced by the chondrocytes 
and synovial cells (Corvol 2000). 
 
The important role of chondrocytes in OA has been suggested based on a mouse 
model. Using the STR/Ort mouse strain, it has been shown that chondrocyte cell 
death correlates with the progression of OA (Mistry et al. 2004). Regions of inactive 
chondrocytes appear in the cartilage, before any major histological evidence of 
degeneration appears (Altman 1981). Based on gene expression results reported by 
Watters et al. (2007), it seems that the default pathway of the mesenchymal cell 
differentiation is changing from adipogenesis towards osteogenesis in the OA mouse 
model. Therefore, as mentioned before, it is possible that chondrocytes are the 
initiative source for the inflammation and pain in the synovium. 
 
Ligaments 
 
All joint tissues seem to play a role, at least at some stage, in OA. Cruciate ligament 
collagen metabolism is upregulated in the STR/Ort mouse compared to controls. 
While at the same time, the anterior cruciate ligament is weaker in STR/Ort mice 
than in controls (Anderson-MacKenzie et al. 1999). 
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Biomechanics and physical stress 
 
As discussed earlier, excessive physical stress predisposes to OA whilst an 
appropriate level of exercise can be protective (Haara et al. 2003; Hart et al. 2008; 
Recnik et al. 2008; Bennell et al. 2010a). One possibility, to clarify the beneficial 
effects of physical activity, could be that the chondrocytes get their nutrients through 
diffusion and convection from the surrounding synovial fluid more effectively. 
Increased use of the joint, pumping the fluids in and around cartilage, could improve 
the nutrition of the cartilage. 
 
It is, however, still not entirely known if the benefits of physical stress are due to the 
loss of adipose tissue and the increase in cardiovascular health, or if the benefits are 
gained due to mild loading of the joints. This question is especially important in the 
case of hand OA, where physical activities like jogging or swimming could be 
beneficial due to the above mentioned process, whereas exercise loading hand joints 
could actually be harmful. The study mentioned earlier (Segal et al. 1998), in which 
hand joints unable to move were protected from OA, speaks for the possibility that 
even mild loading might be harmful and only the other outcomes of physical 
activity, i.e. weight loss and cardiovascular health, would confer beneficial factors. 
It is possible that the beneficial effects seen in the study are due to not using the 
joints, but it is also possible that they are due to not using the hand with too high a 
loading. These aspects need to be studied more and the results need to be replicated 
in larger study samples in order to draw further conclusions. 
 
One interesting question about OA is: Why are all joints not affected by some slight 
OA? The ankle, wrist, elbow, and shoulder are usually unaffected by OA even 
though degeneration of the articular cartilage occurs. Especially fascinating is why 
the ankle is not affected by OA, even though it carries the same or even greater body 
mass than the hip or knee. The answer is not simple or fully known, but it seems to 
involve the cartilage, subchondral bone and the chondrocytes. First of all, the 
extracellular matrix of the cartilage in the ankle has been shown to contain more 
proteoglycan and less water than the cartilage of the knee. This makes the ankle 
cartilage stiff, and low in hydraulic permeability, thereby allowing the cartilage to 
endure high compressive forces better than the cartilage in the knee (Treppo et al. 
2000). Second, the ankle chondrocytes do not seem to respond to catabolic factors as 
strongly as the chondrocytes of the knee, however, they do respond well to removal 
of IL-1 (Eger et al. 2002). Third, it seems that the degeneration of ankle cartilage 
does not increase the subchondral bone density, as opposed to what normally occurs 
in other joints affected by OA (Muehleman et al. 2002). 
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2 .2 .7  M ed ica l  t rea tm en t  
There is no disease preventing treatment for OA. In practice, the first treatment in 
many cases is exercise and muscle strengthening, with weight loss an important 
factor in disease control.  
 
Pain killing medicine, such as paracetamol, is the main medical treatment, along 
with some locally used pain killers. Non-steroidal anti-inflammatory drugs 
(NSAIDs) are also used to some extent, but long term use is limited by their 
gastrointestinal adverse effects. Cyclo-oxygenase-2 (COX-2) inhibitors, that are 
more specific, are also used as treatment. However, their possible cardiovascular 
adverse effects have been under debate. A meta-analysis of 145,373 participants 
using COX-2 inhibitors, NSAIDs or placebo was studied for cardiovascular events 
(Kearney et al. 2006). The authors concluded that COX-2 inhibitors increased the 
risk for severe vascular events compared to placebo (rate ratio 1.42, 95% CI 1.13 - 
1.78; p = 0.003). Further, there seemed to be a similar kind of risk with NSAIDs, 
like ibuprofen and diclofenac, but a lower risk with naproxen. More studies are still 
needed for further conclusions. 
 
Surgery can be used in the treatment of OA. The weight-bearing forces can be 
redirected with osteotomy. Joint replacement surgery is used in a progressed disease, 
when the pain and loss of function is considered to trouble everyday life. Based on 
research evaluating a total of 20 studies, there is systematic evidence that in hip OA, 
total hip replacement surgery remarkably increased the quality of life, usually 
already within the first 3 – 6 months after surgery (Towheed et al. 1996). 
 
 
Future prospects in medical treatment 
 
Currently, some of the molecules and pathways discussed in this thesis work have 
been under research for drug targets by medical companies (Steinmeyer et al. 2006). 
These targets have been widely studied, and their role in OA appears to be crucial. 
Inhibitors for catabolic enzymes are one interesting group. MMP inhibitors such as 
bisphosphanates and tetracycline are under research, since MMPs cleave the 
collagen network in cartilage. Doxycycline has already been shown to slow joint 
space narrowing in knee OA (Brandt et al. 2005). Inhibitors for “disintegrin and 
metalloproteinase with thrombospondin-like repeat” (ADAMTS) family have also 
been under research since ADAMTS break down aggracan (Yao et al. 2002). 
Cathepsin K is another potential drug target. It cleaves type II collagen at several 
sites under the acidic conditions that seem to be present in the OA joint. The gene 
expression of cathepsin K is elevated in OA cartilage, but it is also present in normal 
subchondral bone, in osteoclastas, and mononuclear cells (Konttinen et al. 2002). 
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Inhibitors for glycosidases are under research, since glycosidases cleave HA and 
proteoglycan sugar chains (Liu et al. 2001). The inflammation pathway is another 
study target. Recombinant interleukin-1 receptor antagonist (IL-1RA protein coded 
by IL1RN gene) which is already in use for RA, has raised interest as a possible 
treatment for OA, without success yet (Chevalier et al. 2005). It decreases OA 
symptoms in animal model (Bacconnier et al. 2009).  Inhibiting some intracellular 
signal transduction pathways is also under investigation. Inhibition of mitogen-
activated protein (MAP) kinase is of interest, since it enhances apoptosis and 
production of catabolic factors (Pelletier et al. 2003). While, inhibitors of nuclear 
factor-#B (NF-#B) are interesting, since it stimulates the production of cytokines 
chemokines, and proteins involved in the control of cell death (Tegeder et al. 2004). 
2 .2 .8  P h y s ica l  ac t iv i ty  
It is widely accepted that physical exercise is a key-element in knee and hip OA pain 
management, and in the maintenance of joint function. In 1975, it was shown in a 
small study that 74 Finnish championship runners are not predisposed to hip OA 
compared to the normal population (Puranen et al. 1975). Later it has been widely 
accepted that low-impact physical exercise is beneficial for joints. As Keysor et al. 
(2011) concluded in their systematic study, which included the large collaborative 
consensus recommendation guidelines (Jordan et al. 2003; Roddy et al. 2005; 
Vignon et al. 2006; Zhang et al. 2008; Chodzko-Zajko et al. 2009; Zhang et al. 
2010), that people with knee OA should perform both moderate low-impact activity 
and progressive resistive strengthening exercise. 
 
OA patients should be educated about the positive outcomes of exercise (Roddy et 
al. 2005) as long as the activity is not painful and does not predispose to trauma, 
since they are two risk factors for OA (Vignon et al. 2006). Exercise in general and 
exercise of the hand muscles in hand OA are not widely studied. Therefore the 
usefulness of these exercises are more unclear than in knee and hip OA, but it is still 
recommended (Zhang et al. 2007). 
 
Based on a study by Bennell et al. (2010b), the strengthening of hip muscles 
improved knee OA symptoms but did not affect medial knee load. Thus it is unlikely 
to have directly influenced the structural changes in joint tissues suffering from OA. 
 
Based on the presented data, it seems that physical exercise either affects OA 
through metabolic pathways, possibly by decreasing the amount of adipose tissue 
and related hormones, or by increasing the exchange of nutrients and harmful 
metabolites of chondrocytes within the joint cavity. Exercise does not seem to affect 
the mechanical loading, at least not OA of the knee, but then again the supporting 
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tissues are probably strengthened. Could the effect of exercise in OA be related to 
the range of motion during movement? Discussion on the effectiveness of manual 
physical therapy including manipulation and stretching techniques is ongoing (Rhon 
2008). Some evidence for its usefulness, even when added to the exercise therapy, 
has been shown in a small study of 100 individuals (OR 1.92, 95% CI 1.30 - 2.60) 
(Hoeksma et al. 2004). However, more knowledge is needed about the exact 
biological mechanism, at the molecular level, of the benefits of exercise in OA 
patients. 
 
For knee and hip OA the positive effects of exercise is clear, yet the effect on hand 
OA is less studied, even though it would be biologically more interesting. More 
studies are needed to address the issue of what type of exercise hand OA patients 
should do: mainly hand joint exercises or other types of aerobic and strength 
exercises that are not directly related to the hand joints? 
2.3 Genetic studies of OA 
Previously, candidate gene studies have focused on genes affecting cartilage 
structure, such as asporin (ASPN) (Kizawa et al. 2005; Mustafa et al. 2005; Jiang et 
al. 2006; Shi et al. 2007). However, newer extensive GWA studies have the 
advantage of not requiring knowledge and hypothesis on the gene functions 
beforehand, although interpretation of the findings can be complicated afterwards. 
Recent large GWA studies have revealed entirely new study targets in OA. Next, I 
will discuss studies that show some of the most promising results in this field so far. 
I will classify them based on study type since, to some degree, the study approach 
tells about the reliability and broadness of the study.  
 
It is still difficult to say, if the majority of the OA phenotype is caused by thousands 
of different familial mutations with large effect, or common population based alleles 
with small effects. Since OA is a late-onset disease and the phenotype is not life-
threatening, even in the early-onset familial cases, evolutionary pressure has 
probably been very mild against the disease alleles. Since the disease is related to 
the inflammatory system, the disease-predisposing alleles might even have an 
advantageous effect in survival through some other trait possibly leading to high 
allele frequencies of the OA-risk alleles. In the case in the MCF2L gene 
predisposing to OA, the predisposing allele had a frequency over 90 % while the 
ancestral allele frequency was less than 10 % (Day-Williams et al. 2011). 
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2 .3 .1  G en om e -w id e  a s soc ia t ion  s tu d ie s  in  O A  
GWA studies do not require pre-formulated hypotheses of the genes or gene 
networks involved, but rely on systematic statistical assessment throughout the 
genome. So far eight GWA studies have been conducted in OA (Mototani et al. 
2005; Miyamoto et al. 2008; Zhai et al. 2009; Kerkhof et al. 2010; Nakajima et al. 
2010; Day-Williams et al. 2011; Evangelou et al. 2011; Panoutsopoulou et al. 
2011). However, the coverage of genetic variation in the genome was low (<100.000 
markers) in some of the studies (Mototani et al. 2005; Miyamoto et al. 2008). Four 
GWA studies in OA showed genome-wide significant associations (p < 5x10-8) and 
will be discussed in more detail (Table 1). 
 
 
Table 1. Genome-wide significant findings (p<5x10-8) in OA. Modified from Näkki 
et al. (In press). 
Chr. Variant Gene RAF p 
OR 
(95 % CI) 
n (cases) 
n (controls) 
Phenotype 
Population 
Ref. 
3p24 rs7639618 DVWA/ 
COL6A4P1 
0.64 7.3x10-11 
1.43 
(1.28–1.60) 
1,399  
2,141 
Knee  OA 
Asian 
Miyamoto 
et al. 2008 
6p21 rs10947262  
 
BTNL2 
 
0.58 5.1x10-9 
1.31 
(1.20-1.44) 
1,879  
4,814 
Knee OA 
Asian, 
Caucasian 
Nakajima 
et al. 2010 
 
7q22 rs4730250  
 
DUS4L 
 
0.17 9.2x10-9 
1.17 
(1.11-1.24) 
6,709  
44.439 
Knee OA 
Caucasian 
Evangelou 
et al. 2011 
13q34 rs11842874 MCF2L 0.93 2.13x10-8 
1.17  
1.11-1.23 
 
19,041 
24,504 
Knee OA 
Hip OA 
Caucasian 
Day-
Williams 
et al. 2011 
Chr = chromosome, Variant= rs number of the SNP, RAF = risk allele frequency,  p = 
combined p-value of screening and replication; OR = odds ratio; n(cases) = number of 
cases; n(controls) = number of controls. 
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Further, there are differences in OA phenotyping between and even within studies. 
Susceptibility loci for OA seem to differ between populations, e.g. between Asian 
and European populations. It is possible that a SNP finding in one population does 
not replicate in another population since it tags different haplotypes in different 
populations. 
 
 
Finding on chromosome 3p24: DVWA/COL6A4P1 
 
An association between a marker in “double von Willebrand factor domain A” 
(DVWA) (p = 7.3x10-11) and knee OA was observed by Miyamoto et al. (2008). The 
finding was later replicated (p = 0.018) by Valdes et al. (2009b). However, negative 
association for the studied variant has been published (Meulenbelt et al. 2009; 
Kerkhof et al. 2010). Of interest is that nearby regions on chromosomes 3p21 and 
3p24 have shown suggestive evidence of linkage to hand OA in several studies with 
LOD scores of 2.7 (Hunter et al. 2004) and 2.8 (Livshits et al. 2007). DVWA 
interacts with "-tubulin, which has an essential role in protein trafficking and 
secretion of proteins (Miyamoto et al. 2008). The gene has lately been suggested to 
represent the COL6A4P1 gene (Wagener et al. 2009). The CAPN gene is also 
located in the same LD block making it difficult to pinpoint the contributing gene. 
 
 
Finding on chromosome 6p21: BTNL2 in the HLA region 
 
A variant in the butyrophilin-like 2 gene (BTNL2) in the HLA II locus has been 
associated with knee OA (p = 2.43x10-8) (Nakajima et al. 2010), although, negative 
association in Chinese and Australian study samples have been published for the 
same variant (Shi et al. 2010). The region has shown suggestive evidence for 
linkage to OA (LOD = 2.1) (Loughlin et al. 1999). The region harbors several genes 
from the HLA class II group that are in high LD with each other, including BTNL2, 
HLA-DRA, HLA-DRB5, HLA-DRB1, HLA-DQA1, and HLA-DQB1 (Nakajima et al. 
2010). They all are expressed by antigen presenting cells (B lymphocytes, dendritic 
cells, macrophages) and play an important role by presenting peptides from 
extracellular proteins. The BTNL2 gene negatively regulates T-cell activation 
(Arnett et al. 2007). The true causative variant remains unknown due to the LD in 
the region, but presumably the causative gene is tightly involved in the immune 
system.  
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Finding on chromosome 7q22: DUS4L 
 
A GWA study by Kerkhof et al. (2010) identified a locus on 7q22 to be associated 
with clinical and/or radiological generalized OA (p = 8x10-8). Later meta-analysis on 
Caucasian subjects, including the previous study sample, revealed association near 
the original finding, with the “dihydrouridine synthase 4-like” gene (DUS4L) (p = 
9.17%10&9) and with the “B cell receptor associated protein 29” gene (BCAP29) (p = 
3.90%10&8) (Evangelou et al. 2011). Although, this finding was not replicated in the 
Japanese and Chinese cohorts from the same study. The associated region harbors 
genes DUS4L, COG5, BCAP29, G protein-coupled receptor 22 (GPR22), “protein 
kinase, cAMP-dependent, regulatory, type II, "” (PRKAR2B), and “HMG-box 
transcription factor 1” (HPB1). Again due to the high LD in the region, pinpointing 
the causative variant will be demanding, but some speculation about the eventual 
roles of these genes are discussed next. 
 
GPR22-positive chondrocytes are present in the upper layers of the articular 
cartilage of mice knee joints with induced arthritis and absent from controls 
(Kerkhof et al. 2010). COG5 is involved in formation of the Golgi-localized 
complex (Ungar et al. 2002). BCAP29 is involved in B-cell signaling with the 
Bap29/31 complex seeming to play a role in the trafficking of MHC class I 
molecules (Paquet et al. 2004). PRKAR2B is a signaling molecule involved in many 
cellular functions. HPB1 is involved in cell cycle and the Wnt pathway (Sampson et 
al. 2001). 
 
 
Finding on 13q34: MCF2L 
 
A marker in the “MCF.2 cell-line-derived transforming sequence-like” gene 
(MCF2L) showed association with knee and hip OA (p = 2.13x10-8). There was only 
little LD outside the gene region (Day-Williams et al. 2011). The Mcf2l gene is 
expressed in rat cartilage. It regulates neurotrophin-3 (NTF3) -induced cell 
migration in Schwann cells (Liu et al. 2009). The NTF3 is part of the nerve growth 
factor family (NGF) that could play a role in OA pain, since inhibiting this family 
seems to decrease joint pain and increase joint function (Lane et al. 2010). 
 
 
Still only little is known with high certainty about the genetics behind OA. The 
3p24, 6p21, 7q22, and 13q34 loci seem to have population level, genome-wide 
significance in OA. As in so many other complex diseases, the ORs in these findings 
vary only between 1.2 - 1.8. Proof about true causative genes and variants are in 
most cases still modest, due to the LD in the regions and the lack of extensive 
functional studies. However, the HLA region on 6p21 and the MCF2L gene are 
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highly likely candidates, suggesting pathways involved in the immune system and 
nerve growth. 
2 .3 .2  G en om e -w id e  l in k age  s tu d ie s  in  O A  
Family-based GWL studies and follow-up fine-mapping studies have discovered 
many possibly OA-predisposing loci (Leppävuori et al. 1999; Loughlin et al. 1999; 
Ingvarsson et al. 2001; Demissie et al. 2002; Loughlin et al. 2002b; Stefansson et al. 
2003; Forster et al. 2004; Hunter et al. 2004; Loughlin et al. 2004; Southam et al. 
2004; Greig et al. 2006; Lee et al. 2006; Mabuchi et al. 2006; Meulenbelt et al. 
2006; Livshits et al. 2007; Min et al. 2007; Meulenbelt et al. 2008). Significant 
evidence of linkage has been found for thirteen different loci and OA, based on the 
linkage threshold guidelines of Lander and Kruglyak (1995) (LOD > 3.3). Some of 
the most significant linkage findings have been on chromosomal regions 2p23.3 
(LOD = 4.4) (Stefansson et al. 2003), 2q33.3 (LOD = 6.1) (Meulenbelt et al. 2006), 
and 15q25.3 (LOD = 6.3) (Hunter et al. 2004). These findings will be discussed in 
more detail, Table 2. 
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Table 2. Results from OA linkage studies. Significant linkage findings are presented 
(LOD )  3.3, bold font). In addition, suggestive linkage findings are presented (LOD 
) 1.9, normal font) if they are on a region showing significant linkage in another 
study. In sib-pair studies, thresholds of LOD 3.6 and 2.2 are used respectively 
(Lander et al. 1995). Modified from Kämäräinen (2009) and Näkki et al. (In press).  
Chr LOD Family/sibpair 
Method 
Phenotype 
(details) 
Country Reference 
2p23.3–p24.1 4.4 Families 
Aff. allele share 
Hand 
(DIP/first CMC) 
Iceland Stefánsson 
et al. 2003 
A 
2p23.3 2.2 Families 
Multipoint 
Hand 
(JSN) 
USA Demissie 
et al. 2002 
2p12–p13.3 4.0 Twins 
Multipoint 
Hand 
(TotKL, 
women) 
UK Livshits 
et al. 2007 
2q33.3 6.1 Families 
Two-point 
Generalized 
 
Netherlands Meulenbelt 
et al. 2006 
4q31.3 3.3 Families 
Aff. allele share 
Hand 
(DIP) 
Iceland Stefánsson 
et al. 2003 
4q32.3 3.8 Twins 
Multipoint 
Hand 
(TotKL) 
UK Livshits 
et al. 2007 
6p12 4.6 Families 
Two-point 
Hip 
(THR, female) 
UK Loughlin 
et al. 2002b 
8p23.2 4.3 Family 
Multipoint 
Biomarker 
(PIIANP) 
Afr.Am / 
Nat.Am. 
Chen 
et al. 2010 
9q34.2–q34.3 4.5 Twins 
Multipoint 
Hand 
(DIP) 
UK Livshits 
et al. 2007 
12q21.33–q22 3.9 Twins 
Multipoint 
Hand 
(DIP) 
UK Livshits 
et al. 2007 
B 
13q22.1 3.6 Family 
Multipoint 
Hip 
 
Japan Mabuchi 
et al. 2006 
15q25.3 6.3 Families 
Multipoint 
Hand 
(First CMC) 
USA Hunter 
et al. 2004 
19q13.2 4.3 Twins 
Multipoint 
Hand 
(TotKL) 
UK Livshits 
et al. 2007 
20p13 3.7 Families 
Multipoint 
Hand 
(DIP, women) 
USA Hunter 
et al. 2004 
In the case that several findings were made in the same region and with overlapping study samples, only one 
study is presented, the one with the highest logarithm of odds (LOD) score, even if the study was a 
finemapping study. Family/sibpair = familial or sib-pair study sample; Method = linkage analyses used; Aff. 
allele share = affected only allele sharing method; Multipoint = multipoint linkage analysis; Two-point = two-
point linkage analysis; DIP = distal interphalangeal; CMC = carpometacarpal; JSN = joint space narrowing; 
generalized = generalized OA; TotKL = Kellgren Lawrence score sum for both hands; OST = osteophyte; PIP 
= proximal interphalangeal; TIP = thumb interphalangeal; Association finemapping (p < 0.05) in the region: A 
= MATN3 (Stefansson et al. 2003), B = intergenic (Evangelou et al. 2011). 
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Linkage region of 2p23.3-p24.1 harbors MATN3 
 
A chromosomal region on 2p23.3–p24.1 has shown linkage with hand OA in two 
studies, yielding LOD scores of 4.4 (Stefansson et al. 2003) and 2.2 (Demissie et al. 
2002). A possible disease causing gene MATN3 was finemapped, but the mutation 
found did not fully explain the linkage (Stefansson et al. 2003). The same variant 
might also predispose to disc degeneration (p = 0.02) (Min et al. 2006). Matrilins are 
ECM proteins. MATN3 expression has been shown to be upregulated in the OA 
cartilage of humans (Pullig et al. 2002), and to increase the expression of genes 
encoding TNF-!, IL-1", IL-6, IL-8, iNOS, and COX-2 in chondrocytes obtained 
from human OA cartilage (Klatt et al. 2009). 
 
 
Linkage region of 2q33.3 harbors FRZB 
 
A locus on 2q33.3 showed significant evidence of linkage to generalized 
osteoarthritis (LOD = 6.1) (Meulenbelt et al. 2006), with similar evidence gained in 
a meta-analysis (p = 0.03, 10,000 permutations) (Lee et al (2006) involving several 
other studies (Chapman et al. 1999; Stefansson et al. 2003; Hunter et al. 2004). 
Frizzled-related protein (FRZB) has been suggested to be the predisposing gene in 
several studies (p = 0.007) (Loughlin et al. 2004), (p = 0.02) (Min et al. 2005), (p = 
0.01) (Lane et al. 2006), (p = 0.04) (Valdes et al. 2007). The function of FRZB in 
OA might be due to its role in wingless (Wnt) signaling, which is involved in, 
among others, skeletal metabolism, joint patterning in embryogenesis, and plays a 
role in apoptosis (James et al. 2000).  
 
A larger chromosomal region on 2q12-q34 has been linked to different OA types in 
several studies (Leppävuori et al. 1999; Loughlin et al. 2000; Loughlin et al. 2002a; 
Loughlin et al. 2002b; Hunter et al. 2004; Meulenbelt et al. 2006), but the findings 
have not been statistically significant. An association with interleukin 1 receptor 1 
(IL1R1) in the same region is shown in Study I of the present thesis. 
 
 
Linkage region of 15q25 
 
Significant evidence for linkage has been found between a region on 15q25 and 
hand OA (Hunter et al. 2004) (LOD = 6.25). Further, a trend was seen in a meta-
analysis by Lee et al (2006) (p = 0.04, 10,000 permutations), which included the 
original study sample (Chapman et al. 1999; Stefansson et al. 2003; Hunter et al. 
2004). A predisposing variant is still unknown. 
 
Review of the literature 
THL – Tutkimus 77/2012 40 Search for Susceptibility 
Genes in Osteoarthritis 
For some of the most promising linkage findings presented above, association fine 
mapping has revealed potential causative candidates, but in most cases the proof is 
still modest and the linkage regions are large. The candidate genes neither show 
genome-wide significance (p < 5x10-8) nor fully explain the original linkage 
(Stefansson et al. 2003; Loughlin et al. 2004; Min et al. 2005; Lane et al. 2006; 
Valdes et al. 2007). Thus more evidence is needed for any further conclusions.  
2 .3 .3  C an d id a te  g en e  s tu d ie s  in  O A  
Next I will discuss the variants that have been shown to associate with OA in 
independent candidate gene studies with replication. Only the finding for the GDF5 
is genome-wide significant (p = 1.8x10-13) (Miyamoto et al. 2007), however, the 
other studies are interesting with regards to future efforts to unravel OA genetics. 
Based on familial studies, it seems that rare, familial mutations might have an 
important role in the disease, additionally bringing collagens into the picture. 
 
 
GDF5 on 20q11 showed association with OA in several candidate gene studies 
 
One recently found OA gene is growth and differentiation factor 5 (GDF5). The 
SNP rs143383 has been shown to associate with hip and knee OA in Asian 
populations (p = 1.8x10-13) (Miyamoto et al. 2007), and with knee OA in a European 
population (p = 9.4x10-7) (Evangelou et al. 2009). GDF5 is a member of the 
transforming growth factor- " (TGF- ") superfamily and is related to the bone 
morphogenetic proteins (BMPs) that induce cartilage and bone formation, and 
stimulate de novo synthesis of ACAN protein (Erlacher et al. 1998). Mutations in 
the GDF5 gene cause skeletal alterations both in humans (Thomas et al. 1996) and 
mice (Storm et al. 1994). TGF-" is a pleiotropic cytokine and growth factor that has 
important anabolic effects on chondrocytes. It can stimulate type II collagen 
synthesis and down-regulate cartilage-degrading enzymes. It also has a role in 
decreasing the IL-1 induced suppression of proteoglycan synthesis.  
 
 
ASPN on 9q22 showed association with OA in several candidate gene studies 
 
The association of allele D14 of the asporin gene (ASPN) with hand, knee or hip OA 
has been shown in Japanese, Chinese and Caucasian individuals (0.0008 < p < 0.02) 
(Kizawa et al. 2005; Mustafa et al. 2005; Jiang et al. 2006; Shi et al. 2007). ASPN is 
a member of the ECM SLRP family, which is a group of proteins that bind to other 
proteins in the extra cellular matrix. ASPN can inhibit TGF-" signaling with the D14 
allele showing greater inhibition than the other alleles (Kizawa et al. 2005). 
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DIO2, SMAD3 and ANP32A as candidate genes 
 
Some other interesting associations have been seen between DIO2, on 14q31, and 
hip OA (p = 2.02 x 10–5) (Meulenbelt et al. 2008), and with the SMAD3, 15q22, (p < 
7.5 x 10-6) (Valdes et al. 2010) and “acidic (leucine-rich) nuclear phosphoprotein 32 
family member A14” genes (ANP32A) to hip OA (p < 3.8 x10-4) (Valdes et al. 
2009a). 
 
 
Collagens coding genes 
 
Previously, two biologically interesting and widely studied groups of genes in OA 
genetics were cartilage genes and cartilage degrading genes. As one hypothesis for 
OA related to pathogenesis is based on an imbalance between degradation and repair 
of the cartilage (Ala-Kokko et al. 1990; Horton et al. 1998; Tetlow et al. 2001; Kirk 
et al. 2003; Alizadeh et al. 2005; Jakkula et al. 2005). Compared with the recent 
extensive GWA gene mapping studies, the older studies were conducted with 
smaller sample sizes, fewer markers and candidate genes, and without replication. 
However, many of the studies were performed in families, identifying family-
specific mutations. Many of these studies were used as data sources when candidate 
genes were selected for the three studies presented in this current thesis work, thus 
they are now shortly presented. 
 
One important group of structural genes of relevance for joints and joint diseases are 
the collagens. Table 3 summarizes the types and locations of some of the collagens 
most important to the joint and cartilage. 
 
Type II collagen is the most common collagen in articular cartilage, but collagen 
types III, VI, IX, X, XI, XII and XIV all contribute to the mature matrix. In 
developing cartilage, the basic collagen network is a composite of collagens II, IX 
and XI. Many collagen proteins are formed by several alpha chains coded by their 
own gene (Kuivaniemi et al. 1997; Eyre 2002). 
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Table 3. Collagen types, structures of the collagens and collagen expressing tissues 
based on Eyre (2002) and the National Center for Biotechnology Information 
(NCBI) database. 
Type Structure Tissue 
I Fibrillar Connective tissues, bone, cornea, dermis and 
tendon 
II Fibrillar Eye, main component of cartilage 
III Fibrillar, associated with 
type I collagen 
Skin, lung, uterus, intestine and the vascular 
system, smaller amounts in many tissues rich 
in type I collagen 
V Fibrillar Low abundance, tissues containing type I 
collagen; closely related to type XI collagen 
VI Beaded-filament forming 
collagen 
Cartilage, the major structural component of 
the microfibrils 
IX Fibril associated with 
interrupted triple helices 
(FACIT) 
Articular cartilage, eye, tissues containing 
type II collagen; located on the surface of 
type II collagen containing fibrils 
X Homotrimer, network-
forming collagen 
Hypertrophic chondrocytes during 
endochondral ossification, cartilage 
XI Fibrillar; the !3(XI) chain 
is encoded by the gene for 
type II procollagen 
Cartilage 
XII Fibril associated with 
interrupted triple helices 
(FACIT) 
Cartilage, eye 
XIV Fibril associated with 
interrupted triple helices 
(FACIT) 
Cartilage 
A fibril-forming collagen is a long, thin rod and contains three polypeptide chains called the ! 
chains. These chains are wrapped into highly ordered triple helixes that are made possible by every 
third amino acid being glycine, the amino acid with the smallest side chain (Kuivaniemi et al. 
1997). 
 
 
Variants in many of the collagen genes have previously been associated with OA, 
including COL1A1 (Lian et al. 2005), COL2A1 (Hämäläinen et al. 2008), COL9A1 
(Alizadeh et al. 2005), and COL9A3 (Ikeda et al. 2002). Rare familial variants in the 
genes coding for collagens II and XI have been identified to predispose to OA (Ala-
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Kokko et al. 1990; Jakkula et al. 2005) and to a familial OA-like disease spectrum 
(COL2A1) (Su et al. 2008). Exprssion studies have shown that the expression of 
COL2A1, COL1A2, COL3A1 and COL5A1 increases in OA cartilage in a naturally 
occurring OA in canines (Clements et al. 2006) 
 
 
Aggrecan 
 
One important gene in cartilage structure is aggrecan (ACAN). An association 
between a VNTR polymorphism in ACAN and OA has been observed (Horton et al. 
1998; Kirk et al. 2003), with the same VNTR region in ACAN also being associated 
with disc degeneration (Kawaguchi et al. 1999; Solovieva et al. 2007). As 
mentioned earlier, ACAN is an important part of cartilage, responsible in part for its 
elasticity. A functional mouse study with the STR/Ort model showed that aggrecan 
gene transcription is elevated in early osteoarthritis (Gaffen et al. 1997). 
 
 
Matrix metalloproteinases (MMPs) 
 
Matrix metalloprotinases (MMP) are a group of extracellular matrix breaking 
enzymes, neutral endoproteinases. MMP-1, MMP-8 and MMP-13 are the best 
known enzymes to break down fibrillar collagens. MMP-1 best breaks type III 
collagen, MMP-8 type I collagen and MMP-13 type II collagen. MMP-3 and MMP-
10 break down proteoglycans. MMPs are inhibited by tissue inhibitors of 
metalloproteinases (TIMPs). Factors like the IL-1" pathway (Stern et al. 2003; 
Riyazi et al. 2005; Moxley et al. 2007; Kanoh et al. 2008) have been shown to affect 
MMP-8 expression. MMP-8 has low expression in normal chondrocytes but is up-
regulated by IL-1" (Cole et al. 1996), and there seems to be co-expression between 
the two (Tetlow et al. 2001). 
 
Macrophages, fibroblasts and chondrocytes synthesize MMP-1 and MMP-13 
proteins in the presence of inflammation. The MMP1, MMP3, MMP8 and MMP13 
genes are expressed in OA cartilage (Tetlow et al. 2001). Additionally, the 
expression of MMP13 when stimulated by IL-1 and TNF-! has been shown to 
increase OA of joints in an animal model (Clements et al. 2006).  
 
 
Interleukins 
 
Inflammation in OA joints is one widely studied topic, with somewhat consistent 
results. The role of the interleukin-1 gene family cluster on chromosome 2q12-13 
has been suggested in hip, knee, or hand OA in Study I of the present thesis in 
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addition to other studies (Moos et al. 2000; Loughlin et al. 2002a; Meulenbelt et al. 
2004; Solovieva et al. 2009). These findings have not been confirmed, including 
those of Study I in the present thesis work. The evidence is at its most convincing 
for the widely studied IL1B and IL1RN genes that cause and inhibits inflammation 
repectively. These genes show suggestive association with knee and hip OA (p = 
0.006 for haplotype; 5000 knee OA cases, 9000 controls) (Kerkhof et al. 2011). 
 
IL-1 and TNF-! inhibit chondrocyte production of type II collagen – the most 
important collagen type in cartilage. IL-1 and TNF-! are both activators of signaling 
pathways of c-Jun N-terminal kinase (JNK), p38 MAP kinase (p38 MAPK) and NF-
#B. All three lead to the inhibition of the COL2A1 gene (Robbins et al. 2000; Seguin 
et al. 2003). Excessive mechanical stress might activate these pathways. Matrix 
metalloproteinases (MMPs 1, 3, 8, and 13), IL-1", and TNF-! are present in the 
superficial zone of OA cartilage. This zone also harbors chondrocyte clusters and 
degenerative matrix changes (Tetlow et al. 2001). Cytokines increase the expression 
of these matrix metalloproteinases, as well as some aggrecanases (Goldring et al. 
2008). Interleukin 6 (IL-6) is a pleiotropic pro-inflammatory cytokine and its 
expression is increased by tissue inflammation in OA cartilage, serum and synovial 
fluid (Kaneko et al. 2000). It has been shown through a knockout mouse model that 
OA is more severe if IL-6 is not present compared to wild-type mice (de Hooge et 
al. 2005). As for many other genes discussed here, strong evidence for disease gene 
variants is still missing.  
2 .3 .4  B iom ark ers  an d  exp res s ion  s tu d ie s  
For a broader view on OA, I will shortly discuss biomarker and gene expression 
studies. Since OA has an inflammatory feature there are probably molecules 
affecting OA that could be seen in a systemic level. Biomarkers also form an 
interesting study subject in scientific studies and potential diagnostic tools. The 
expression and biomarker studies presented here are all significantly affected either 
by a small number of studied samples, a small number of studied genes, or a small 
number of studied biomarkers. Thus either the risk of false positive findings is high 
or the study has not systematically covered numerous possible factors affecting OA. 
In many studies both these limitations are present and the results should be 
interpreted with caution. 
 
Genome-wide expression profiling has been performed by Karlsson et al. (2010), 
among others. This group studied the gene expression profile of healthy (n = 5) and 
osteoarthritic human cartilage (n = 5), and revealed that expression was significantly 
changed for many different groups of genes. The study had the capacity to analyze 
over 47, 000 transcripts. Among many other genes, the expression differed between 
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the two groups for cytokines (such as tumor necrosis factors, TNFs), chemokines 
(like IL-8), enzymes (such as MMPs), growth factors (like IGFs), matrix 
components (like collagen type I), and others (such as HLA-DQA1). In another 
study based on candidate gene expression analysis, SOX9 (p < 0.001) and ACAN (p 
< 0.001) seemed to be down-regulated in osteochondral samples of OA patients (n = 
20) compared to controls (n = 8) (Brew et al. 2010). Additionally, locally expressed 
glycosidases seem to play a role in OA as well as in RA. These determine the final 
structures of glycans (Pasztoi et al. 2009). 
 
The expression of genes involved in the development and function of connective 
tissue, and in lipid metabolism has been shown to be most significantly up-regulated 
during disease progression in the STR/Ort mouse joints (Watters et al. 2007). 
 
In a serum-based metabolomic study of OA, the ratio of two branched-chain amino 
acids, valine, leucine or isoleucine, to histidine was associated with the disease (Zhai 
et al. 2010). Chen et al. (2008) performed a candidate biomarker study using human 
blood samples from an extended family with no known specific disease (n = 287). 
Three of the studied biomarkers showed some level of heritability (heritability > 43 
%) and were also associated with OA (p < 0.05): HA, COMP and type IIA collagen 
N-propeptide (PIIANP). PIIANP is a marker of a fetal form of collagen II which is 
also produced in OA cartilage. The COMP molecule binds to the collagenous 
structure in cartilage and can initiate the alternative complement pathway 
(Happonen et al. 2010). HA has a role in cartilage structure as mentioned earlier and 
also plays an important role in the synovial fluid. 
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3 AIMS 
 
The aim of this thesis study was to investigate the role of 25 structural, degenerative 
and inflammatory candidate genes in OA using SNPs. The purpose was to find gene 
variants that predispose to OA. Three different study settings were used: hand OA 
families and healthy controls, a case-control setting for knee OA, and a twin pair 
study with an MRI based hip OA phenotype. 
 
The specific aims of this thesis were: 
 
I) To identify an OA-predisposing gene for hand OA on the 2q11.2 region. In a 
previous study, the genomic region of 2q11.2 showed linkage to hand OA 
(Leppävuori et al. 1999). The aim was now to identify the OA-predisposing 
gene variant in that region. 
 
 
II) To study if MMP8 and MMP9 genes predispose to OA. Levels of proMMP-8 
and proMMP-9 have been shown to be higher in the serum of OA patients 
than in controls (Tchetverikov et al. 2004). The aim was now to analyze the 
MMP8 and MMP9 genes in knee OA study samples, in order to find out if 
there are genetic variants in these genes that predispose to knee OA. 
 
 
III) To study the role of ACAN, COL, MMP and IL candidate gene groups in hip 
OA. In a previous study, 25 candidates from the ACAN, COL, MMP and IL  
gene groups which were selected based on their previously identified 
biological relevance, were studied for disc degeneration traits in a twin study 
sample (Videman et al. 2009). The aim was now to analyze the same SNP 
panel in the same study population with a hip OA phenotype using MRI-
visible bone changes. 
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4 MATERIALS AND METHODS 
4.1 Study samples 
The study design was approved by the Ethical Committees of the National Public 
Health Institute, Helsinki, Finland (currently National Institute for Health and 
Welfare), the Department of Public Health at the University of Helsinki, Helsinki, 
Finland, the Hospital District of Helsinki and Uusimaa, Helsinki, Finland, the 
Faculty of Rehabilitation Medicine at the University of Alberta, Edmonton, Canada, 
and the Ethical Committee for Clinical Research of Galicia, Spain. The project 
numbers for the ethical approvals are 131/2006 (H, N, I); 9/270598 (B, D); 37/96, 
2/96 (A); 407/E3/2000 (E, F, K, L); 140/E3/2004, 344/E3/2000 (C,J); 2008/063 (G, 
M), letters indicate the study sub-sample referred to, see Table 4. 
 
The study sample was composed of 5941 subjects (1466 OA cases and 4475 
controls) for the study of OA of hand, knee, and hip OA (Table 4). 
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Table 4. The number of cases and controls in studies I-III.  
a = Familial study sample, of which 85 were unrelated. In addition, 34 healthy family 
members were used in the analyses, but are not shown in the table; b = 28 individuals 
were part of clinical hand osteoarthritis (OA) cases and radiological knee OA cases; c = 
MRI based hip OA phenotype; 226 individuals from this group were also part of the 
control group I; A-N = Study samples are referred in the text with the letter; vs. indicates 
which control and case groups were compared with each other;  Ma = male, Fe = female; 
bold font = main analysis; normal font =  validation analysis; HBCS = Helsinki Birth 
Cohort Study; H2000 = Health 2000 study; MRI = magnetic resonance imaging. 
 
Study samples vs. Tot. Ma Fe Study 
Cases        
Hand OA cases        
A)   Radiologicala  104 42 62 I  II  
B)   Clinicalb  28 5 23    
C)   Clinical [HBCS]  524 169 355  II   
Knee OA cases        
D)  Radiologicalb  113 27 86 I II  
E)   Clinical discovery cases [H2000]  75 25 50  II   
F)   Clinical verification cases [H2000]  302 102 200  II  
G)   Joint replacement patient [Spanish]  254 50 204  II  
Hip OA cases        
H)   MRI based  94 94 0   III 
Controls        
I)   Clin. non-OA A+B 436 277 159 I II  
J)   Clin. non-hand OA [HBCS] C 970 490 480    
K)  Clin. non knee/hip OA [H2000]  D+E 895 415 480  II   
L)   Clin. non knee/hip OA [H2000] F 1700 761 939  II  
M)  Clinical non-knee OA[Spanish] G 449 290 159  II  
N)   MRI based non-hip OAc H 251 251 0   III 
In total  5941      
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4 .1 .1  C ases  
 
Radiological familial hand OA study subjects and clinical hand OA subjects 
 
Families and individuals with hand OA were collected from the Mini-Finland Health 
Survey (Kärkkäinen 1985), the Finnish twin-cohort study (Kujala et al. 1999), the 
Rheumatism Foundation Hospital (Heinola, Finland) (Vikkula et al. 1993), and the 
ORTON Orthopaedic Hospital (Helsinki, Finland). In total 168 study subjects were 
collected. Altogether, 134 of them were affected, of which 85 were unrelated. DIP 
OA status was mainly radiologically examined (Studies I and II) (Table 4, A).  
 
The DIP OA phenotype studied was based on radiological Kellgren classification 
(Kellgren 1963) with individuals of stage 3-4/4 DIP OA considered as affected. 
Subjects were invited to participate in a hand x-ray examination, if they were 
recorded as having hand OA based on a clinical evaluation as part of the Mini-
Finland Health Survey, (Kärkkäinen 1985), if they were recorded as having a 
physician-diagnosed hand OA based on a questionnaire from the Finnish twin-
cohort study in 1995  (Kujala et al. 1999), or identified through the Rheumatism 
Foundation Hospital (Heinola, Finland) (Vikkula et al. 1993)  and the ORTON 
Orthopaedic Hospital (Helsinki, Finland). Other family members were included as 
affected individuals if they had a DIP OA score of 2-4/4. All other family members 
were classified as unknown. The average age at grading of hand X-rays was 62 
years (SD 9 y).   
 
In addition, 28 clinically diagnosed hand OA cases (Table 4, B) were included 
which were also included in the knee OA study group (Table 4, D). For clinical 
diagnostics, see Haara et al. (2003). Subjects with clinical or radiological 
rheumatoid arthritis (RA) were excluded. 
 
 
Verification sample: Clinical hand OA study subjects  
 
Subjects from the Finnish Helsinki Birth Cohort Study were studied to verify any 
association results in Study II (Barker et al. 2005) (Table 4, C). They were all above 
the age of 56 years and their hand joints were visually evaluated for Heberden’s 
nodes. If at least one DIP joint was affect, the individual was ranked as affected. 
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Radiological knee OA study subjects 
 
In total 113 subjects with radiological knee OA were analyzed in Studies I and II 
(Table 4, D). They suffered from primary bilateral knee OA severe enough to fulfill 
the criteria for knee arthroplasty: pain, walking disability and radiologically stage 3-
4/4 osteoarthritic changes according to KL classification (Kellgren et al. 1957). OA 
symptoms began at a mean age of 52 years (SD 12 years), with the mean age at first 
arthroplasty being 67 years (SD 8 years). The study was initiated by reviewing 852 
patient reports of hospital visits for knee OA, between 1994 and 2001, to the 
ORTON Orthopaedic Hospital (Helsinki, Finland). Of these, 113 subjects had not 
had a major knee trauma, and volunteered to participate in the study by providing a 
DNA sample. Of the 113 individuals, 28 had severe physician-diagnosed hand OA 
and were also included in the hand OA study sample. In total 110 of the 113 patients 
were used as part of the initial discovery sample in Study II. 
 
 
Clinical discovery and verification knee OA cases 
 
Clinician diagnosed knee OA cases and controls were analyzed in Study II. The 
cases were from a subset of the Finnish Health 2000 cohort (2118 individuals) 
ascertained for a matched case–control study for metabolic syndrome (Perttilä et al. 
2009) and genotyped using the Illumina HumanHap 610 k GWA chip (Illumina, 
Inc., San Diego, CA, USA). Of the 2118 genotyped individuals, 75 had clinician 
diagnosed probable or definite knee OA, based on physical status, symptoms, and 
medical history, and were over the age of 50 years. Radiographic assessment of OA 
was not included in this study (Table 4, E). Individuals suffering from seropositive 
or -negative RA or having unknown RA status, were excluded. Cases with 
radiological knee OA (Table 4, D) were combined with this group. 
 
For verification of any association finding in Study II, the remaining Finnish Health 
2000 study sample was genotyped. This study sample included 302 clinical knee OA 
cases selected using the same criteria as in the discovery phase (Table 4, F). 
 
 
Verification sample: Joint replacement knee OA cases 
 
In total, 254 Spanish knee OA cases were used in a replication analysis of Study II 
(Table 4, G). Cases had undergone knee joint replacement surgery and had severe 
primary OA based on a rheumatologists evaluation. Exclusion criteria were 
inflammatory, infectious, traumatic or congenital joint pathology, and lesions due to 
crystal deposition or osteonecrosis (Rodriguez-Lopez et al. 2007).  
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Hip OA cases 
 
The hip OA study sample was part of the Finnish Twin Cohort called the Twin 
Spine study (Videman et al. 1998; Kaprio et al. 2002; Battié et al. 2007). The 
original Twin Spine study consisted of 588 Finnish monozygotic or dizygotic male 
twins aged 35-70 years. The twin pairs were selected for the Twin Spine study based 
on discordance for specific exposures to low back pain and disc degeneration, such 
as exercise participation, occupational driving, heavy material handling, and 
sedentary work. The twins did not necessarily suffer from back problems.  
 
The precise phenotype in the present study was MRI-based calcified structure 
changes that were also visible in radiographs. Imaging of the hips was performed 
using a Siemens Vision 1.5 T, scanning both hips at the same time using a body 
matrix coil. Analysis of the scans was done using a Siemens MRI workstation at the 
Puijon Magneetti Oy company (Kuopio, Finland). The grading scale was based on 
Li et al (1988) and Kellgren and Lawrence (1957). The trait was dichotomized so 
that individuals with both hip joints normal according to a MRI hip image grade of 0 
were considered as healthy, while individuals with at least small local osteophytes in 
caput or acetabulum (grades 1-4) in at least one hip were considered as affected, 
yielding a phenotype allowing for early-onset OA. One randomly selected individual 
from each monozygotic pair and both twins from the dizygotic pairs were included 
in the genetic analyses. Based on the dichotomization criteria, 94 individuals were 
classified as affected with hip OA (Study III) (Table 4, H). 
4 .1 .2  C on tro l s  
 
Clinical non-OA controls 
 
The first set of control subjects (n = 436, aged 35-70) (Studies I and II) (Table 4, I) 
were selected from the Finnish twin cohort (Kaprio et al. 2002). Initially, 210 
unrelated individuals were selected from the twin sample using the inclusion criteria 
of being born between 1938 and 1941, responded to a questionnaire during the years 
1996-1997, gave DNA samples for analysis, and that both twins reported that neither 
them nor their mother, father or any other sibling had physician diagnosed OA or 
RA. Second, 226 individuals were selected from the Twin Spine study that was used 
in the hip OA study (III). Subjects with physician-diagnosed OA without imaging 
were excluded, and only one twin from a pair was included. 
 
 
 
Materials and methods 
THL – Tutkimus 77/2012 52 Search for Susceptibility 
Genes in Osteoarthritis 
Verification sample: Clinical non-hand OA controls 
 
Controls originating from the Finnish Helsinki Birth Cohort Study were also 
involved in the study (Barker et al. 2005) (Table 4, J). They were above the age of 
56 years and had visually healthy and symptomless finger joints (n=970). 
 
 
Clinical non-knee/hip OA controls in discovery and verification 
 
From the Health 2000 study, a total of 895 individuals were over 50 years of age and 
did not have clinically diagnosed probable or definite knee or hip OA. These 
individuals were used as knee OA controls (Study II) (Table 4, K). Individuals 
suffering from seropositive or -negative RA or having an unknown RA status were 
excluded. 
 
In total, 1700 controls were selected using exclusion of the criteria used for the 
clinician diagnosed OA criteria in the discovery study sample. These were used in 
verification analysis and were genotyped using a different genotyping platform 
(Table 4, L). 
 
 
Verification sample: Clinical non-knee OA controls 
 
Altoghter 449 individuals from Spain, older than 55 years of age and undergoing 
pre-operative work-up for elective surgeries other than joint surgery, were used as 
knee OA controls in the verification analysis of Study II (Table 4, M). They did not 
have OA based on clinical diagnosis. 
 
 
Clinical non-hip OA controls 
 
In total, 251 hip OA controls (Study III) (Table 4, N) were selected from the 
individuals participating in the hip OA study of the Finnish Twin Spine study 
sample. The controls had healthy hip joints based on the MRI grading. 
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4.2 Marker selection and genotyping 
4 .2 .1  M ark er  s e l ec t ion  
A total of 166 SNPs in 25 structural, degenerative and inflammatory candidate genes 
were selected for Study III. The studied genes were ACAN, COL1A1, COL1A2, 
COL2A1, COL3A1, COL5A1, COL5A2, COL9A1, COL9A2, COL9A3, COL10A1, 
COL11A1, COL11A1, MMP3, MMP8, MMP9, MMP13, IL1R1, IL1R2, IL1RL1, 
IL1RL2, IL18R1, IL1RAP, IL1A and IL1B. The criteria for SNP selection was, a 
minimum heterozygosity of 20 % in the Caucasian population and 10 kb spacing 
between SNPs. Two different databases were used to select SNPs. Initially, the 
SNPper program was used (Snpper CHIP Bioinformatics Tools © 2001-2008, 
University of Florida, Gainesville Florida, USA; http://snpper.chip.org (Riva et al. 
2001; 2002; 2004)), which utilizes the UCSC Human Genome Browser database 
(University of California, Santa Cruz Santa Cruz, California, USA; 
http://genome.ucsc.edu (Lander et al. 2001; Kent 2002; Fujita et al. 2010)). 
Secondly, the SeattleSNPs database was used (SeattleSNPs. NHLBI Program for 
Genomic Applications, SeattleSNPs, Seattle, WA, USA; 
http://pga.gs.washington.edu). Five of the 166 SNPs were selected based on 
previous association findings: rs7533552 in COL9A2 (Annunen et al. 1999) 
(Noponen-Hietala et al. 2003), rs2857401 flanking COL1A1 (Garcia-Giralt et al. 
2002), rs1800012 in COL1A1 (Grant et al. 1996), rs412777 in COL1A2 (Suuriniemi 
et al. 2003), and rs9277933 in COL11A2 (Maeda et al. 2001). 
 
The same IL1 SNPs analysed in Study I were studied in Study III. For Study II, tag 
SNPs for MMP8 and MM9 genes were selected as presented in the Illumina 
HumanHap 610 GWA chip (Illumina, Inc., San Diego, CA, USA). 
4 .2 .2  D N A  ex trac t ion  an d  gen o typ in g  o f  th e  s tu d y  sam p les  
DNA was extracted from peripheral blood leukocytes using standard methods of 
phenol DNA extraction, salt precipitation extraction, silica-membrane-based 
purification (DNA Blood Maxi Kit, Qiagen, Venlo, The Netherlands) and 
Chemagen MSMI magnetic bead technology (PerkinElmer, Inc. Waltham, MA, 
USA). 
 
Genotype data was obtained using the following methods: the homogeneous 
MassEXTEND™ (hME) and iPLEX Gold platforms in the Sequenom MassARRAY 
system (Sequenom Inc., San Diego, California, USA), the Microarray based allele 
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specific primer extension method (Silander et al. 2005), by capillary sequencing 
(ABI3730xl DNA Analyzer, BigDye Terminator v3.1 Cycle Sequencing Kit, Life 
Technologies Corp., Carlsbad, CA, USA), the Illumina HumanHap 610 GWA chip 
(Illumina, Inc., San Diego, CA, USA), and the SNaPshot Multiplex Kit (Applied 
Biosystems, Foster City, CA, USA) with the Abi-Prism 3130xl Genetic Analyzer 
(Applied Biosystems). 
 
The Sequenom MassARRAY system is discussed in more detail here, since the 
other methods were run, at least partly, through a core-facility. 
 
 
The Sequenom MassARRAY system 
 
The 99 SNPs in studies I and III were genotyped using hME and iPLEX Gold 
technologies on the Sequenom MassARRAY platforms (Sequenom Inc., San Diego, 
California, USA) as recommended by the manufacturer with additional quality 
control steps (Silander et al. 2003). These systems are based on allele-specific 
primer extension and separation of different alleles, by matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (Sequenom 
Inc. 2002; Sequenom Inc. 2005).  
 
Assays were designed into multiplexes using the SpectroDESIGNER 1.3 (Sequenom 
Inc., San Diego, California, USA) and MassARRAY Assay Design v3.1 (Sequenom 
Inc., San Diego, California, USA) programs. These design PCR and extension 
primers, arranging the SNPs into multiplexes, of 2-6 SNPs for the hME technology, 
and 13-20 SNPs for the iPLEX technology. Genotyping of the samples was done in 
384 well plates and the mass spectrums were analyzed by the SpectroTYPER RT 2.0 
software (Sequenom Inc., San Diego, California, USA) for the hME technology and 
by the MassARRAY Typer software when using the iPLEX technology (Sequenom 
Inc., San Diego, California, USA). 
 
Prior to OA sample genotyping, the SNPs that comprised a multiplex for the hME 
technology were validated by genotyping them singularly on 12 test samples. In 
order to determine that the SNPs are polymorphic in the studied population, and to 
confirm that the assays performed acceptably. Next, the hME and iPLEX 
multiplexes were optimized. This is perfomed by genotyping them as multiplexes on 
test samples, so that adjustments to the amounts of PCR and extension primers for 
each SNP assay in the multiplex can be made. For the hME system, 23 test samples 
and 1 empty well was used while for the iPLEX system 47 test samples and 1 empty 
well was used. 
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Sample plates included 8 empty wells and 8 duplicate samples for quality control. In  
the hME technology, all genotypes were manually read using the spectrograms of 
the SpectroTYPER RT 2.0 software (Sequenom Inc., San Diego, California, USA). 
SNP was excluded from the study if; there were alleles in empty sample wells, the 
allele peaks of the SNPs were consistently low (less than 2, when normally between 
3 - 120), the allele peaks were significantly lower compared to extension primer 
peaks (less than 20 % of the height of extension primer), or if the allele pattern of 
heterozygous samples were inconsistently variable skewed (other allele peak was 
approximately 50 % higher in some of the samples and 50 % lower in others). 
Afterwards, the clustering option of the MassARRAY Typer software was used to 
verify the reliability of the hME assays. 
 
In the iPLEX technology, MassARRAY Typer was used to perform genotype 
reading. Mainly the genotype clustering was used to assess the reliability of the SNP 
assays, while spectrograms were used as supportive information. Genotypes were 
clustered according to their signal intensity and their signal intensity ratio to the 
extension primer peak intensity. Outlier genotypes were set to unknown. Also, if 
more than half of the assays were unsuccessfully readable in a well, all genotypes of 
that well were set to missing. In the iPLEX technology observing allele spectrums in 
empty wells is not an uncommon phenomenon, therefore only if an assay showed 
alleles in all of the empty wells was it excluded from the study. 
 
Additionally, 30 trio families consisting of mother, father and child, were added to 
the sample plates for quality control purposes. The trio samples were used to test if 
any of the SNP alleles were transmitted from the parents to the child against the 
Mendelian laws of inheritance using the PedCheck 1.1 Program. In a case of several 
families showing inheritance against the Mendelian laws, the SNP was excluded 
(O'Connell et al. 1998).  
 
Only SNPs with a call rate over 90 % were included in the association analysis. 
Deviation from the Hardy-Weinberg (HW) equilibrium was tested using Pearson’s 
chi-square test (Purcell et al. 2007). SNPs passing the quality control in validation, 
optimization, and sample genotyping were taken into the association analyses.  
 
 
Capillary sequencing 
 
Two SNPs in the COL9A2 gene (Study III) were genotyped by sequencing the 
region harboring the SNPs, since they were both in the same codon (ABI3730xl 
DNA Analyzer, BigDye Terminator v3.1 Cycle Sequencing Kit, Life Technologies 
Corp., Carlsbad, CA, USA). Sequence chromatograms were manually read. Two 
empty wells in each 96 well plate were used as a quality control.  
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Illumina HumanHap 610 GWA chip 
 
Two genes, MMP8 and MMP9, were selected for analysis (Study II). Genotypes for 
the controls in the Finnish knee OA discovery study sample (Table 4, E, K) were 
obtained from the Illumina HumanHap 610 GWA chip (Illumina, Inc., San Diego, 
CA, USA). The quality control criteria used for exclusion were; MAF less than 1 %, 
genotyping success rate less than 95 % for a marker or individual, HWE less than p 
= 10-6, piHat value more than 0.1 (on a scale 0-1), and no discrepencies between 
reported and genetic gender. Chromosome Y and mitochondrial DNA were not a 
part of this study. 
 
The remaining portion of the genotypes were obtained using The Sequenom 
MassARRAY iPLEX system as described above (Table 4, D, F, L) or with the 
SNaPshot Multiplex Kit (Applied Biosystems, Foster City, CA, USA) and Abi-
Prism 3130xl Genetic Analyzer (Applied Biosystems) (Table 4, G, M). 
4.3 Statistical analyses 
To analyze which of the selected candidate genes play a role in OA, association 
analyses were performed in all three studies. The LD pattern of the studied areas, 
gene tagging, and haplotypes were also studied. 
4 .3 .1  H er i tab i l i ty  
Heritability estimates were performed in the twin sample (Study III) (Professor 
Jaakko  Kaprio’s laboratory, Department of Public Health, University of Helsinki). 
First, polychoric correlations for MZ and DZ twins were calculated separately and 
then heritability was estimated using the Mx software (Neale, M.C., Virginia 
Commonwealth University, Richmond, Virginia, USA). Quantitative genetic models 
allowing for additive genetic, common, and unique environmental variance in the 
liability were used. 
4 .3 .2  S ta t i s t i ca l  p ow er  
Statistical power calculations were done in Study I, in order to evaluate the power to 
detect similar association in another study sample as was detected in Study I. The 
aim was also to calculate the amount of cases required for another study sample to 
Materials and methods 
THL – Tutkimus 77/2012 57 Search for Susceptibility 
Genes in Osteoarthritis 
have 90 % power of detecting a similar association as in Study I (Purcell et al. 
2003). 
4 .3 .3  G en e  tagg in g  
The Tagger program (de Bakker et al. 2005) was used in order to reveal what 
percentage of the ungenotyped SNPs in the studied gene region are captured by the 
used SNP panels (Studies II and III). The program is based on HapMap data (The 
International HapMap Consortium et al. 2003). An r2 threshold of 50 % and 80 % 
between two markers was used (Study III and II respectively). In other words, when 
a SNP is in r2 correlation of more than 80 % with another SNP, the SNPs are tagged 
by one another and are representing similar genotypic information 
4 .3 .4  C orrec t ion  for  m u l t ip l e  t e s t in g  
After obtaining the genotype data, and due to forthcoming multiple testing, the next 
step was to evaluate p-value threshold for 5 % significance in the association 
analysis (Studies I-III). The Single Nucleotide Polymorphism Spectral 
Decomposition (SNPSpD) method (Nyholt 2004) with modifications by Li and Ji 
(Li et al. 2005) was used to calculate the p-value threshold for 5 % significance. 
This method took into account the LD between studied SNPs and thus is not as 
conservative as performing Bonferroni correction. 
4 .3 .5  A sso c ia t ion  an a ly s i s  
 
SNP association analysis 
 
A (2 test was conducted using either Plink (Purcell et al. 2007) or Haploview 
(Barrett et al. 2005). If 5 or less individuals carried a genotype, either in the case or 
in the control group, the 2-Tail Fisher’s exact test ((Agresti 1992) © Øyvind 
Langsrud) was used instead. The analysis methods assume indivduals to be 
unrelated. Therefore only one person per family was included in the familial (Study 
I) and in the twin study samples (Study III). 
 
For all three studies (I-III), familial association was calculated using the 
Pseudomarker program 0.9.7 beta, which can utilize combined data of individual 
cases, sib pairs, families and healthy controls and separate the linkage evidence from 
evidence for association (Hiekkalinna et al. 2011a; Hiekkalinna et al. 2011b). Both 
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dominant and recessive modes of inheritance were used. The association was 
calculated taking into account the possible presence of linkage. 
 
In Study II, the meta-analysis option of Cochran-Mantel-Haenszel was used in Plink 
to assess the overall effect size of the SNP combining different populations and 
phenotypes (Purcell et al. 2007). 
 
 
LD structure and haplotype association analysis 
 
The Haploview program (Barrett et al. 2005) was used to determine the pair-wise 
LD between SNPs (r2 and D’ value) within the studied gene regions (Studies I-III), 
and to identify LD block structures using the r2 measure and the solid spine of LD 
algorithm implemented in the Haploview program. D’ allows correlation between 
markers with different allele frequencies (Lewontin 1964). The solid spine of LD 
defines the block in such a manner that the first and last marker in a block are in 
strong LD with all markers between them, but the intermediate markers need not to 
be in LD with each other (Barrett et al. 2005). 
 
In Study I, haplotype association analysis was performed using the Haploview 
program (Barrett et al. 2005) for the haplotypes containing the best individual 
associated SNPs. The SNPs located in IL1R1 formed one LD block based on the r2 
measure. Haplotypes were also formed for a larger SNP panel forming one LD block 
based on the “solid spine of LD” measure. 
 
To calculate odds ratios (OR), individual haplotypes for each study subjects were 
estimated using the Phase2 program (Stephens et al. 2001; Stephens et al. 2003). A 
minimum probability of ) 60 % was requested for each haplotype. Alleles with a 
frequency of over 5 % in the control sample were each analyzed separately with the 
less common haplotype alleles being grouped together. Hardy-Weinberg equilibrium 
was calculated for the tested haplotypes to confirm the correctness of the haplotype 
allele distribution (p > 0.05). 
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5 RESULTS AND DISCUSSION 
5.1 IL1R1 associated with hand OA (I) 
The IL1 gene region was originally selected for the study due to a suggestive linkage 
finding at chromosome 2q12 (Z = 2.34 at recombination fraction 0) in a previous 
DIP OA study by Leppävuori et al. (1999) with a partly overlapping study sample to 
Study I. Further, other findings have shown evidence for the relevance of this region 
in knee and hip OA (Moos et al. 2000; Meulenbelt et al. 2004; Smith et al. 2004). 
Of the 16 genes in the 2 Mb linkage region, the IL1 gene family of six genes was 
selected for further study, based on their biological relevance and the fact that the 
IL1R1 gene is located at the highest Zmax linkage peak. The IL1R2, IL1R1, IL1RL2, 
IL1RL1, IL18R1, and IL18RAP genes are located in a 470 kb cluster on chromosome 
2q12-14. 
 
IL-1 is a pleiotropic cytokine involved in inflammatory and immune responses. A 
complex of either IL-1! or IL-1" in combination with IL-1R1 and IL-1RAcP 
activates NF-#B (Bomsztyk et al. 1990; Beg et al. 1993). This pathway leads to the 
inflammatory and immune response (Sen et al. 1986). 
 
In Study I, a total of 168 familial subjects were genotyped, of which 134 were 
mainly radiologically diagnosed to have DIP OA. Additionally, 435 healthy controls 
were included in the study. In total, 32 SNPs were analyzed (Table 4 A, B, I). 
5 .1 .1  S ign i f i can t  a s soc ia t ion  w i th  S N P  r s2287047  
The IL1R1 region was fine-mapped in the current association study to reveal 
variants underlying hand OA. The Pseudomarker program (Hiekkalinna et al. 2011a; 
Hiekkalinna et al. 2011b) was used for family based association analysis. The (2 
and Fisher’s exact tests were used to confirm the finding in unrelated individuals 
excluding one individual from each per twin (85 hand OA cases, 435 controls). 
Altogether 32 SNPs were analyzed. Association with severe hand OA was 
concentrated on the region harboring the long promoter and coding region of the 
IL1R1 gene (Table 5). 
 
Association was seen for SNP rs2287047 to severe hand OA (OR for AA vs. GG = 
0.16, 95% CI = 0.06 - 0.45; OR for AA vs. AG = 0.26, 95% CI = 0.09 - 0.73; 
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protective A allele being the minor allele; p = 0.00091 dominant mode of 
inheritance). This association was statistically significant after correction for 
multiple testing. The p-value threshold that corresponds to significance at the 5 % 
level was 0.0021, based on SNPSpD (Nyholt 2004; Li et al. 2005). Based on this 
results, the IL1R1 gene region was studied further.  
 
 
Table 5. Single SNP association results between IL1R1 gene area and hand OA. 
Gene SNP id MAF p-value 
  Controls Hand OA (2 Dominant 
IL1R1 rs1465325 0.195 0.119 0.022a 0.005 
 rs956730 0.260 0.204 0.140a 0.026 
 rs3917225 0.396 0.309 0.043 0.078 
 rs2287047 0.249 0.159 0.013a 0.00091 
 rs3771200 0.411 0.453 0.312 0.539 
IL1RL2 rs2241132 0.158 0.141 0.644a 0.491 
 rs870684 0.378 0.394 0.690 0.781 
 rs1922290 0.377 0.420 0.304 0.495 
 rs1922295 0.379 0.400 0.613 0.696 
 rs1997502 0.353 0.318 0.375 0.681 
 rs2302612 0.119 0.157 0.199a 0.505 
a = Fisher’s exact test; Dominant = association p-value with dominant model of the 
Pseudomarker program (Hiekkalinna et al. 2011a, Hiekkalinna et al. 2001b).  
 
 
For confirmation of the original linkage observed, linkage of the region was 
analyzed using the Pseudomarker program (Hiekkalinna et al. 2011a; Hiekkalinna et 
al. 2011b) in the hand OA families. SNP rs956730 showed the strongest evidence 
for linkage to hand OA (LOD = 1.34, p = 0.006, two-point linkage, dominant 
model). 
5 .1 .2  H ap lo typ e  tagged  b y  r s1465325  a s soc ia ted  w i th  h an d  O A  
The LD block of the promising region was studied in controls using the Haploview 
program (Barrett et al. 2005). Associated SNPs seemed to be in LD with each other 
(D’ LD ) 94 %; r2 LD ) 34 %) (Figure 6). Next, SNPs in LD with each other were 
selected for haplotyping. 
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Figure 6. The LD block structure of IL1R1 and IL1RL2 genes in the control sample. 
Above the r2 measure of LD, below the D’ measure of LD. The pair-wise LD is shown as 
different shadings of grey (r2) and red (D’). The LD blocks selected for haplotyping are 
marked with black triangle (Barrett et al. 2005).  
 
 
Haplotypes were analyzed to gain further understanding of the allelic background in 
the IL1R1 area. First, SNPs in the IL1R1 gene were selected for haplotyping 
(rs1465325, rs956730, rs3917225, rs2287047, rs3771200; D’ LD > 83 %, r2 > 15 
%). Haplotype CAAAG was observed to be the protecting allele as it was rarer in 
cases (0.104) than in controls (0.188) [OR for “heterozygous for CAAAG” vs. 
“homozygous for others” = 0.54; 95% CI = 0.41 to 0.72; p = 0.0079 based on the 
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Phase2 (Stephens et al. 2001; Stephens et al. 2003) and the Haploview programs 
(Barrett et al. 2005)]. 
 
 
Table 6. IL1R1 haplotype frequencies and the p-value for the association (one 
haplotype versus all other haplotypes) based on the Haploview program (Barrett et 
al. 2005). 
Haplotype Allele frequencies p-value 
 Controls Hand OAa  
TGGGA 0.381 0.440 0.147 
TGGGG 0.218 0.212 0.865 
CAAAG 0.188 0.104 0.0079 
TGAGG 0.115 0.123 0.772 
TAAAG 0.053 0.048 0.796 
a = one individual per family 
 
 
Secondly, the solid spine of LD algorithm, as used in the Haploview program, was 
used to select SNPs for confirmatory haplotype association analysis (Barrett et al. 
2005). SNPs rs1465325, rs956730, rs3917225, rs2287047, rs3771200, rs2241132, 
rs870684, rs1922290, and rs1922295 were used (D’ LD ) 94 % for rs1465325 with 
other markers; D’ LD ) 86 % for rs1922295 with other markers). Based on this 
confirmatory analysis, the CAAAGCTGC haplotype seemed to protect from hand 
OA as it was rarer in the hand OA cases (0.101) than in controls (0.190) (p = 
0.0058).  
 
The rs1465325 SNP appears to tag the protective allele (OR CT vs. TT = 0.59, CI = 
0.45 to 0.78; p = 0.022). 
5 .1 .3  P ow er  in  th e  k n ee  O A  sam p le  
Based on the Genetic power calculator (Purcell et al. 2003), at least 503 knee OA 
cases would have been required to have 90% power to detect this association, when 
assuming a similar effect size as observed in the family-based severe hand OA, with 
an allele frequency of 0.84 and prevalence of 7 %. The power to detect association 
with the 113 knee OA cases used in Study I was only 12 %. 
 
The effect size of the studied SNP (rs2287047) might have been an over-estimate 
due to the limited sample size. Since, assuming an effect size typically seen in 
complex diseases (risk ratios for a single SNP 1.15 - 1.20), approximately 4000 
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cases are required to detect similar association with 80% power (allele frequency of 
0.75 and prevalence of 10 %). 
5 .1 .4  The  ro l e  o f  I L 1 R 1  in  O A  
To conclude, association was detected between severe hand OA and four SNPs in 
the IL1R1 gene. The strongest evidence for association was observed with the 
rs2287047 SNP (p = 0.00091) located in intron 1 of the IL1R1 gene. The other three 
associated SNPs are located in the long promoter region of the gene. 
 
 
 
Figure 7. Flowchart of the two studies on IL1R1 and hand OA. Suggestive evidence of 
linkage between hand OA and chromosome 2q11-q21 was observed in a genome-wide 
scan by Leppävuori et al. (1999). Association fine-mepping was performed in an 
extended hand OA study sample in Study I and variants in IL1R1were observed to 
“associate” with hand OA. 
 
 
One hypothesis for the role of this finding in OA is that the associated SNP region 
affects the gene expression of IL1R1 gene. Altered expression levels of IL1R1 could 
further affect NF-κB signaling, resulting in elevated expression levels of other 
inflammatory components leading to an increased tendency to inflammatory 
reactions in hand joints. However, the IL1R1 gene variants could affect OA in a 
number of other ways, due to the complexity of NF-κB signaling.  
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IL-1β binds to the IL-1R1 protein that is widely expressed in different tissues on the 
cell surface. The roles of the IL1 gene family members in this pathway are presented 
in Figure 8. The IL-1 – IL-1R1 – IL1RAcP complex starts the pathway, leading to 
the phosphorylation of inhibitory κB (IκB) with the help of inhibitory κB kinase 
(IKK). The release of IκB enables NFκB to promote the expression of corresponding 
genes, including IL1A and IL1B. The IL1RN gene codes for the IL-1Ra protein 
which inhibits the binding of IL-1α and IL-1β to their receptor IL-1R1. (O'Neill et 
al. 1998; Debets et al. 2001; Subramaniam et al. 2004; Towne et al. 2004; Roman-
Blas et al. 2006).   
 
 
 
Figure 8. IL1 gene family memebers and activation of NFKB. Green color indicates a 
proinflammatory and red color an anti-inflammatory molecule (O'Neill et al. 1998; 
Debets et al. 2001; Subramaniam et al. 2004; Towne et al. 2004; Roman-Blas et al. 
2006). 
 
 
The role of the IL-1 pathway in OA has been previously studied. Firstly, the 
production of the IL-1β (by the IL1B gene) and the IL-1Ra (by the IL1RN gene) 
proteins was shown to be high in OA patient blood samples stimulated with LPS 
when compared to control blood samples stimulated with LPS (Riyazi et al. 2005). 
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Secondly, a study by Fernandes et al. (1999) showed that injection of the IL-1Ra 
(IL1RN) plasmid gene, into menisectomized rabbit knee, reduced the progression of 
OA. Thirdly, anakinra, a recombinant IL-1Ra protein, has been shown to decrease 
the symptoms in erosive OA patients (Bacconnie et al. 2009). However the results 
have not been unequivocal (Chevalier et al. 2009), this is possibly due to the short 
half life of anakinra (a few hours) and thus therapeutically too low concentrations 
were attained in the study (Martel-Pelletier et al. 2009) or because of a low affect in 
OA. Anakinra was approved for use in the treatment of RA by the European 
Commission European union in 2002. 
 
The four associated SNPs of this study were located in the non-coding region of 
IL1R1. Three of them were in the long, highly polymorphic promoter region 
(rs1465325, rs956730, rs3917225) (Smith et al. 2004). It is possible that the studied 
SNPs, or other SNPs in high LD with the studied ones, affect the expression of the 
IL1R1 gene or other genes in the same region. Three SNPs (rs1465325, rs3917225, 
rs2287047) co-localized with predicted transcription factor binding sites. In all three 
cases the conserved allele matched with the consensus sequence of a transcription 
factor binding site, while the other allele changed the site either to another 
transcription factor binding site or caused a loss of the binding site (Computational 
Biology Research Center CBRC, http://www.cbrc.jp/index.eng.html). 
 
The role of the pathway from IL-1" to NF-#B activation is important for microbial 
defense. Mice deficient in IL-1" are more susceptible to several microbial infections 
compared to wild type mice (Netea et al. 2010). Survival from microbial infections 
has been, and still is, likely to be one of the many key issues for survival of a 
species. In comparison, joint wellbeing in later age is probably one of the least 
important characteristics for evolutionary survival. 
 
Study I was the first study to show an association between IL1R1 and OA. The 
IL1R1 gene did not show significant association with knee OA, possibly due to 
either lack of importance in knee OA or lack of power in the knee OA study group. 
The IL1R1 gene has been associated with other diseases like AIDS progression (Do 
et al. 2006) and endometriosis (D'Amora et al. 2006).  
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5.2 MMP8 associated with knee OA 
The aim of Study II was to investigate if there were allelic variants of MMP8 and 
MMP9 genes that would associate with knee OA. A Finnish discovery sample of 
185 knee OA cases, with either clinical (n=75) or radiological (n=110) diagnosis, 
and 895 controls were analyzed (Table 4, D, E, K). Based on the results, one SNP in 
MMP8 gene was further genotyped in a Finnish knee OA verification sample of 302 
clinical knee OA cases and 1700 controls (Table 4, F, L) and in a Spanish knee OA 
verification sample of 254 knee OA cases and 449 controls (Table 4, G, M). 
Furthermore, a Finnish hand OA verification sample 1, consisting of 132 familial 
radiological hand OA cases and 435 controls, was analyzed (Table 4, A, I) as along 
with a second Finnish hand OA verification sample, consisting of 524 visually 
evaluated hand OA cases and 970 controls (Table 4, C, J). Meta-analysis was 
performed analyzing all knee OA and hand OA cases as two separate phenotypes 
and jointly as one OA phenotype. 
5 .2 .1  S ign i f i can t  S N P  as soc ia t ion  w i th  on ly  on e  s tu d y  sam p le  
Altogether, 13 tag SNPs were studied in the MMP8 and MMP9 genes and analyzed 
using Plink (Purcell et al. 2007). The main finding of Study II was for the SNP 
rs1940475 located in the MMP8 gene (Table 7). The initial finding was observed 
with the Finnish knee OA discovery sample (OR = 0.721 95 % CI 0.575 - 0.906; p = 
0.0049). A similar trend was seen in the Finnish knee OA verification sample, the 
Spanish knee OA verification sample, and the Finnish hand OA verification 
samples, but without statistical significance. Meta-analysis combining all study 
samples yielded a p-value of 0.028 (OR = 0.904, 95 % CI 0.827 - 0.989) (1369 OA 
cases, 4445 controls). The p-value threshold for 5 % significance was 0.0057 for the 
initial finding (Nyholt 2004; Li et al. 2005). The effect was stronger in the Finnish 
study sample than in the Spanish. 
 
The same magnitude of significance was seen with another SNP (OR = 0.710, 95 % 
CI 0.562 - 0.895; p = 0.004; rs3765620). Both SNPs are non-synonymous. The SNP 
rs1940475 changes a positively charged OA protecting lysine to a negatively 
charged OA predisposing glutamic acid (Lys87 to Glu), while the SNP rs3765620 
changes a protective polar threonine to a predisposing non-polar isoleucine (Thr32 
to Ile). For both SNPs, the predisposing allele was the common, ancestral allele. 
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Table 7. Results of an association analysis on MMP8 in the Finnish knee OA 
discovery sample. 
SNP (allele) 
Freq 
ctrls 
Freq 
cases 
(2 
p-value OR L95 U95 
rs12274992 (T) 0.051 0.074 0.088 1.470 0.942 2.293 
rs3740938 (A) 0.074 0.068 0.688 0.913 0.587 1.422 
rs2012390 (C) 0.205 0.186 0.417 0.888 0.666 1.183 
rs1940475 (T) 0.493 0.413 0.0049 0.721 0.575 0.906 
Finnish knee OA verification sample 0.473 0.454 0.371 0.924 0.776 1.099 
Spanish knee OA verification sample 0.462 0.461 0.966 0.995 0.800 1.239 
Knee OA META   0.039 0.884 0.787 0.994 
Finnish hand OA verification sample 1 0.484 0.428 0.187 0.798 0.571 1.116 
Finnish hand OA verification sample 2 0.474 0.465 0.639 0.965 0.830 1.121 
Hand OA META   0.332 0.934 0.814 1.072 
OA META   0.028 0.904 0.827 0.989 
rs7123682 (C) 0.129 0.159 0.132 1.271 0.930 1.738 
rs3765620 (G) 0.446 0.363 0.004 0.710 0.562 0.895 
rs7943404 (G) 0.378 0.431 0.060 1.245 0.990 1.565 
rs10895354 (C) 0.129 0.159 0.125 1.277 0.934 1.746 
(allele) = allele for which the allele frequencies are shown; OA = osteoarthritis; META = 
meta-analysis of study samples above; Freq = allele frequency; ctrls = controls; OR = 
odds ratio; L95 = lower 95 % confidence interval; U95 = upper 95 % confidence 
interval. 
5 .2 .2  M M P 8  r eg ion  i s  in  on e  L D b lock  
The LD block structure was analyzed using the Haploview program (Barrett et al. 
2005). Controls of the Finnish knee OA discovery sample were used in this analysis. 
The D’ measure takes into account the differences in allele frequencies allowing 
strong correlation for mutations occurring at different times throughout evolution.  
The MMP8 gene is located in one LD block based on the D’ measure. The two SNPs 
associating with knee OA are in high LD with each other (r2 = 82 %). 
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Figure 9. The LD block structure of the MMP8 gene in the Finnish controls of the 
Finnish discovery knee OA sample. Above the r2 measure of LD, below the D’ measure 
of LD. The pair-wise LD is shown as different shadings of grey (r2) and red (D’) (Barrett 
et al. 2005). 
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5 .2 .3  T h e  ro le  o f  M M P 8 in  O A  
The MMP-8 protein (neutrophil collagenase, collagenase 2) cleaves collagens type I, 
II, III, other ECM compounds, and non-structural molecules (Barksby et al. 2006). 
A major source of MMP-8 is the neutrophils (Lazarus et al. 1968), which are 
essential cells in acute response to pathogens. Neutrophils appear in inflamed tissues 
within minutes to hours from contact with a pathogen. A mesenchymal form of the 
MMP-8 molecule is expressed by chondrocytes following a proinflammatory 
stimulus (Barksby et al. 2006), rheumatoid synovial fibroblasts and human 
endothelial cells (Hanemaaijer et al. 1997), osteoblastic progenitors, differentiated 
osteoblasts, osteocytes, and chondrocytes in the growth plate (Sasano et al. 2002), 
all of which might explain the connection between MMP8 and OA. 
 
The role of MMP-8 in OA has been suggested by the following studies: Increased 
expression of MMP-8 is associated with increased cleavage of type II collagen in 
OA in human osteoarthritic articular cartilage. MMP8 mRNA was present in OA 
cartilage but absent from normal cartilage (Shlopov et al. 1997; Chubinskaya et al. 
1999) and the levels were higher in chondrocytes obtained from areas surrounding 
OA lesion compared to other areas of the cartilage (Shlopov et al. 1999). The 
expression is not however, elevated in the synovium (Davidson et al. 2006). A 
similar trend was seen in cartilage immunostaining (Tetlow et al. 2001). MMP-8 
levels were higher in blood of OA patients compared to controls (Tchetverikov et al. 
2004). 
 
TNF-! increases MMP-8 expression (Stannus et al.; Shlopov et al. 1999; Tetlow et 
al. 2001; Guler-Yuksel et al. 2010; Riepl et al. 2010). Inhibition of MMP-8 could be 
an important target in the prevention of the development of OA. Tetracycline 
(Suomalainen et al. 1992), doxycycline (Lauhio et al. 1994; Shlopov et al. 1999), 
and Ro 32-3555 (Trocade) (Lewis et al. 1997) could be potential treatments for OA 
due to their ability to decrease the levels of MMP-8. However, the important role of 
MMP-8 in other pathways including cancer related pathways (Balbin et al. 2003; 
Palavalli et al. 2009) raises the question of possible risks associated with this type of 
OA treatment. 
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5.3 COL9A2 and COL10A1 in hip OA 
The heritability of the studied hip OA phenotype was 72 % (95% CI 49–87 %). 
Altogether 99 SNPs in 25 candidate genes were studied.  The studied genes were 
ACAN, collagen genes (COL1A1, COL1A2, COL2A1, COL3A1, COL5A1, COL5A2, 
COL9A1, COL9A2, COL9A3, COL10A1, COL11A1 and COL11A1), matrix 
metalloproteinase genes (MMP3, MMP8, MMP9 and MMP13), and interleukin and 
interleukin receptor genes (IL1A, IL1B IL1R1, IL1R2, IL1RL1, IL1RL2, IL18R1, and 
IL1RAP). In total, 94 hip OA cases and 251 controls were analyzed (Table 4, H, N). 
 
The Tagger program was used to analyze, how well the genetic variance in the 
studied regions, was tagged by the studied SNPs. Coverage (r2 = 50 %) was 42 % on 
average, varying from 0 % to 80 % (COL9A2). 
5 .3 .1  S u gges t ive  ev id en ce  for  a s soc ia t ion  
The main association findings concentrated on the COL9A2 and COL10A1 genes (p 
< 0.01) (Table 8). None of the findings reached the 5 % threshold for significance 
that was set at 0.00073, based on SNPSpD analysis (Nyholt 2004; Li et al. 2005). 
 
 
Table 8. Association of SNPs in COL9A2 and COL10A1 genes with hip OA as 
analyzed using the Pseudomarker program (Hiekkalinna et al. 2011a; Hiekkalinna et 
al. 2011b) and (2.test. The significance threshold was 0.00073. 
Gene SNP id MAF p-value 
  Controls Hip OA (2 Dominant 
COL9A2 rs449541 0.340 0.289 0.287 0.158 
 rs364281 0.397 0.386 0.817 0.920 
 rs12077871 0.010 0.014 1.000a,b 0.215 
 rs7533552 0.130 0.308 0.0021a,c 0.003 
COL10A1 rs549332 0.434 0.507 0.157 0.179 
 rs1064583 0.396 0.306 0.066 0.030 
 rs3812111 0.394 0.297 0.053 0.024 
 rs568725 0.383 0.250 0.006 0.0015 
a = Fisher’s exact test; b = Trp versus combined Arg and Gln alleles; c = combined Arg 
and Trp alleles versus Gln; Dominant = dominant mode in the familial association 
analysis performed with Pseudomarker (Hiekkalinna et al. 2011a; Hiekkalinna et al. 
2011b). 
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Three SNPs in moderate LD with each other (r2 ) 60 %) showed a trend towards 
association in COL10A1 (p = 0.0015, dominant mode of inheritance, the 
Pseudomarker program (Hiekkalinna et al. 2011a; Hiekkalinna et al. 2011b)).  
 
This was the first time when a common SNP (rs7533552, alternative name 
rs2228564) in the COL9A2 gene, on chromosome 1p34.2, was identified to associate 
with hip OA (p = 0.003). What makes this finding especially interesting, is a 
previous Finnish association finding between the same locus and disc degeneration 
(the Trp allele) in the same study sample (Videman et al. 2009). 
 
The predisposing G allele changes a codon of a non-polar amino acid, glutamine 
(Gln326), to a positively charged arginine (Arg), or to tryptophan (Trp) when 
together with a rare T allele in the SNP next to it (rs12077871). The locus was 
sequenced with capillary sequencing to define the genotypes of both variants and, 
therefore, to reveal the amino acid for each individual. Eleven individuals carried a 
Trp allele as a combination of C/T heterozygote for SNP rs12077871 (1st base) 
together with A/G heterozygote or G/G homozygote for SNP rs7533552 (2nd base). 
This indicated that the minor alleles T and G of the two studied SNPs were inherited 
together (D’ LD = 100 %, r2 LD = 4 %, calculated using the Haploview program 
(Barrett et al. 2005) (Table 9) (Figure 10). 
 
 
Table 9. The COL9A2 finding in hip OA in Study III. The number of different 
amino acid combinations in unrelated hip OA cases and in controls for the Gln326 
codon that contains two SNPs. 
1st base 
rs12077871 
2nd base 
rs7533552 
3rd base 
 
Corresponding 
amino acid 
Controls 
(n)     (%) 
Hip OA 
(n)    (%) 
C A G Gln 
C A G Gln 
96 67.1 36 49.3 
        
C A G Gln 
C G G Arg 41 28.7 28 38.4 
        
C A G Gln 
T G G Trp 3 2.1 1 1.4 
        
C G G Arg 
C G G Arg 
3 2.1 7 9.6 
        
C G G Arg 
T G G Trp 0 0.0 1 1.4 
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Figure 10. The LD patterns of the studied SNPs in COL9A2 and COL10A1 genes 
according to the Haploview program (Barrett et al. 2005). Above the r2 measure of LD, 
below the D’ measure of LD. The pair-wise LD is shown as different shadings of grey 
(r2) and red (D’) (Barrett et al. 2005). 
 
 
The Odds ratio was calculated by comparing amino acid counts of the wild-type Gln 
allele with the OA predisposing Arg or Trp alleles between the hip OA cases (45 
predisposing alleles, 101 wild-type alleles) and controls (50 predisposing alleles, 
236 wild-type alleles). The disease OR for carrying either of the predisposing 
variant alleles Arg or Trp versus the wild-type allele Gln was 2.10 (95% CI 1.66–
2.67; p = 0.0021, Fisher’s exact test). It seemed that the Trp allele was not 
associated with hip OA when compared with Arg and Gln alleles combined, but due 
to the limited number of individuals carrying the Trp allele, conclusion on its 
independent role cannot be drawn. 
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5 .3 .2  The  ro l e  o f  C O L 9 A 2  a n d  C O L 1 0 A 1  in  O A  
The hip OA predisposing variant in COL9A2 (Figure 11) seemed to have a 
pleiotropic effect. The same predisposing G allele (Arg326 or Trp326) associated with 
lumbar disc degeneration (p = 0.036 after 1000 permutations; disc bulging in discs 
L1-L4) in a previous study of the same twin sample (Videman et al. 2009). In 
addition, a similar trend was seen in a German population. The Arg amino acid was 
less frequent in controls than in patients suffering from “lumbar disc disease” and in 
those surgically treated for intervertebral disc herniation. The association did not, 
however, reach statistical significance (Knoeringer et al. 2008). 
 
 
 
Figure 11. Location of the variants in COL9A2 gene on chromosome 1p34.2. bp = 
base pair location coordinates; Gene = the COL9A2 gene, exons are marked as boxes; 
Cons = conservation on the area between mammals on a scale (+2)-(-3); LD is shown 
as the r2 measure. Modified from UCSC Genome Browser on Human Mar. 2006 
Assembly and Haploview (Barrett et al. 2005). 
 
 
The rare amino acid change Gln326 to Trp (“the Trp2 allele”) has been associated 
with intervertebral disc disease with associated sciatica in Finns (Annunen et al. 
1999). The Trp2 allele has also been shown to play a role in a degenerative lumbar 
spinal stenosis in Finns (Noponen-Hietala et al. 2003). Finnish patients carrying the 
Trp2 allele have been shown to be more flexible according to the modified Schober 
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measure, and they more often have a radial tear in a non-herniated disc compared to 
controls (Karppinen et al. 2002).  Surprisingly, the Trp2 allele seems to be relatively 
common in the Southern Chinese population, occurring in 20 % of the population. 
Where it is an age-dependent risk factor for the development and severity of a 
“degenerative disc disease” phenotype (associated with it in the age group of 40-49 
years), for the development of anular tears (associated with it in the age group of 30-
39 years), and Schmorl’s nodes (associated with the age grouop of 40-49 years) (Jim 
et al. 2005). Additionally, the Trp2 allele was shown to associate with disc 
degeneration in Japanese patients less than 40 years of age (Higashino et al. 2007). 
The Trp2 allele was associated with the deteriorating mechanical properties of the 
nucleus pulposus as early as adolescence, when no other signs of disc degeneration 
were present (Aladin et al. 2007). 
 
Of special importance to the present study, is that the SNP rs7533552, in the 
COL9A2 gene and moderately associating with hip OA, is likely to be an actual 
disease causing variant rather than a marker in high LD with such a variant. As 
discussed earlier, type IX collagen contains sequences that form triple-helical 
domains and plays a role in balancing the type II collagen by forming cross-links 
with it. Based on the present results, it can be hypothesized that a change from 
glutamine to either arginine or tryptophan affects the triple helical structure, thereby 
weakening the cartilage of the hip and intervertebral discs. However, based on the 
PolyPhen protein structure prediction program, only the change from glutamine to 
tryptophan was predicted as possibly damaging (Division of Genetics, Department 
of Medicine, Brigham and Women’s Hospital – Harvard Medical School, 
Cambridge, MA, USA; http://genetics.bwh.harvard.edu/pph/). 
 
Other variations in COL9A2 gene have been shown to associate with intrafamilial 
phenotypic diversity in multiple epiphyseal dysplasia (Takahashi et al. 2006). The 
COL9A2 gene encodes one (alpha 2) of the three alpha chains of type IX collagen, 
which is usually found in tissues containing type II collagen. Type IX collagen plays 
a role in load bearing cartilages by organizing and stabilizing the network of 
collagen fibrils. Deficiency in !1(IX) chains leads to a dysfunction of type IX 
collagen. However, it was shown that type IX collagen is not essential for formation 
of the fibril network, instead the protein is required for long term tissue stability 
(Hagg et al. 1997). The other two alpha chains in type IX collagen have also been 
associated with disc disease and OA, the alpha 1 chain displayed an association with 
disc degeneration in a previous study on twins (Videman et al. 2009) and it has been 
associated with hip OA.  
 
Three neighboring SNPs showed some level of association with hip OA in the 
COL10A1 gene on chromosome 6q22.1 (Figure 12). The most significant p-value in 
the COL10A1 gene was obtained for SNP rs568725 (p = 0.0015). The SNP 
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rs1064583, which showed only a modest association with hip OA (p = 0.0245), is 
located in an exon and changes the amino acid methionin to threonine (Met27 to 
Thr). Interestingly, there is another gene, Homo sapiens 5'-nucleotidase domain 
containing 1 (NT5DC1) in the same location, but the direction of this gene is 
opposite to that of the COL10A1. 
 
The COL10A1 gene (Figure 12) encodes three alpha 1 chains of the type X collagen 
homotrimer. It is expressed by hypertrophic chondrocytes during endochondral 
ossification, and can thus be considered as a marker for new bone formation in 
articular cartilage (Shen 2005). Type X collagen was found in the osteoarthritic 
cartilage of the hip, but was absent from normal adult cartilage (Boos et al. 1999). 
 
 
 
Figure 12. Location of the variants in COL10A1 gene on chromosome 6q22.1. Bp = 
base pair location coordinates; Gene = genes in the area, boxes represent the exons and 
continuous line represent the introns; Cons = conservation on the area between 
mammals on a scale (+2)-(-3); LD is shown as the r2 measure. Modified from UCSC 
Genome Browser on Human Mar. 2006 Assembly and Haploview (Barrett et al. 2005). 
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5.4 Limitations of the study 
The three most significant limitations of the present thesis work were, the limited 
sample sizes, lack of replication, and the insufficient marker coverage of the genes 
studied. 
5 .4 .1  S am p le  s i ze   
A small sample size reduces the power for the detection of SNPs of low-effect, 
which are likely to be typical in complex diseases. In the present thesis work, the 
number of individuals studied, and especially the number of individuals affected, 
was not high enough for sufficient power to detect low-effect variants, or to exclude 
the relevance of a gene to a phenotype. For instance in Study I, the required number 
of cases was 500 to have 90 % power for detection of the observed association 
signal, which, further, might have been an over-estimate (OR = 0.26). Genome-wide 
association signals of p < 5x10-8 with typical ORs of about 1.25 (Wellcome Trust 
Case Control Consortium 2007) would require 6000 cases and 6000 controls for 
detection (Hirschhorn et al. 2005). The small sample size, therefore, increases the 
risk for false positive findings. 
5 .4 .2  P h en o typ in g  
Most disease phenotypes cannot be biologically divided into groups of healthy and 
affected individuals, but the phenotypes are usually continuous quantitative traits, as 
discussed earlier. In the present study, the populations were divided into two groups, 
healthy and affected, based on their OA grade or clinical evaluation. Some 
individuals in these two different groups might still be biologically very similar to 
each other. A pure quantitative trait could have given a better starting point for the 
study. However, developing a reliable quantitative measurement for OA, that is also 
heritable, is still a challenge. 
 
Additionally, the grading of the hip OA using MRI was originally performed for the 
disc degeneration study, and only individuals imaged with the method were included 
in the present study. There were a few individuals excluded that had gone through 
joint replacement surgery, and thus, were unable to participate in the MRI grading 
due to the metallic object now in their body. Moreover, severe forms of OA might 
significantly limit physical activities such as walking, and, therefore, such 
individuals may not participate in these studies. 
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5 .4 .3  G en e  coverage  
The SNP panels in studies I and III were designed before the availability of the 
HapMap genotyping database (The International HapMap Consortium et al. 2003) 
and thus the tagging SNP method was not used. Without such knowledge of the LD 
structure of the genome, revealed by the HapMap project, the SNPs were selected to 
cover the studied genes in terms of equal physical distance. The number of SNPs 
and their locations was later found not to be optimal. 
 
Furthermore, a large number of SNPs were excluded from the study during the strict 
quality control stage. Therefore, the SNP panels in these studies did not cover the 
genes sufficiently, and variants affecting the disease may have been missed. On the 
other hand, the tagging system based on HapMap linkage disequilibrium data has 
been criticized, since a disease causing SNP could be missed even when genotyping 
a tag marker in high LD with it (Terwilliger et al. 2006). 
5 .4 .4  S tu d ied  p o p u la t ion  
The population structure of the study subjects was not taken into consideration when 
planning the study. However, both hand and knee OA study samples were collected 
from nationwide cohorts or from national hospitals specialized in rheumatic 
diseases. Recently published data shows that subjects originating from different 
parts of Finland are heterogeneous in their genetic background, even if the total 
amount of variance is lower than in other European populations (Jakkula et al. 
2008). However, the GWA data of the Finnish Health 2000 sample showed 
relatively homogenous genetic background between the clinical knee OA cases and 
controls (Table 4, K, E), with a p-value greater than 0.1 for the difference between 
cases and controls for the 10 most significant principal components describing the 
genetic heterogeneity of the two groups.  
5 .4 .5  L a ck  o f  r ep l i ca t ion  
For validation of a finding the results should be replicated in a larger sample set to 
verify association with OA. Until then, the presented results should only be 
considered as a possible starting point for future studies. Future GWA and whole-
genome sequencing studies will cover the studied areas and, therefore, should shed 
more light on these findings. 
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5 .4 .6  S ta t i s t i ca l  s ign i f i can ce  o f  th e  f in d in gs  
In the present study, association analyses were performed using the (2 test and the 
Pseudomarker program’s dominant and recessive models. Performing the 
association test in three different ways increases the number of statistical tests 
performed. However, these tests are still highly dependent on each other. That is 
why they were not corrected for separately, which would have decreased the p-value 
threshold of significance. Further, some of the SNPs were in high LD with each 
other. These factors were taken into account in the correction of multiple testing. 
With some of the SNPs considered as one test and the tests of different inheritance 
models also considered as one test. 
 
Today, the emerging technology of whole-genome sequencing in large study 
samples enables positive findings with p-values of several magnitudes larger in size. 
A genome-wide significance level of 5x10-8 is not obtainable with the sample sizes 
used here or with the number of SNPs studied. The current findings should be 
considered as an implication of a possible association, and therefore as a base for 
future studies. 
5 .4 .7  B io log ica l  m ean in g  o f  th e  f in d in gs  
Clinically and diagnostically, these findings are still far from practical applications 
in terms of medical treatment for OA. Evidence for an eventual role of the IL1R1 
variant in OA is needed, and similarly protein structure analysis corresponding to 
the MMP8 and COL9A2 findings are needed. 
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6 CONCLUSIONS AND FUTURE PROSPECTS 
In this thesis, association between OA and SNPs in several biologically relevant 
candidate genes was analyzed. Association was observed between hand OA and the 
IL1R1 gene (p = 0.00091, with a significance threshold of p = 0.0021), knee OA and 
the MMP8 gene (p = 0.0049, with a significance threshold of 0.0057), and between 
hip OA and the COL9A2 and COL10A1 genes (p = 0.0021 and p = 0.0015, with a 
significance threshold of 0.00073). However, due to the small sample sizes and the 
moderate strength of the findings, these results need to be replicated in larger sample 
sets in order to verify their true importance in the etiology and pathogenesis of OA. 
Today, with the commonly used GWA methods and large sample sets of tens of 
thousands study subjects, p-value thresholds of p < 5x10-8 are considered as 
statistically significant, with newer technologies that will perform whole-genome 
sequencing likely to decrease this limit further. Compared to the newer knowledge 
and studies, which are possible to conduct today, the current findings are of 
moderate value. However, it is important to emphasize the fact that the association 
with the ILR1 gene was found in a region previously indicated in a linkage study on 
the same study sample. While, the finding for MMP8 showed a similar trend in 
several study samples, even if not in a statistically significant manner, and the codon 
in the COL9A2 gene had associated with disc degeneration in a previous study 
(Videman et al. 2009). 
 
For the association findings presented in this thesis work for the IL1R1, MMP8 and 
COL9A2 genes, it is important to replicate them in other larger study samples, 
including both Finnish cohorts and cohorts of other ethnic backgrounds.  
 
In general, extending the studied samples with new samples would be of use. 
Another way to proceed could be by collecting a new large OA study sample with 
known common ancestors from an isolated population, so as to perform exome or 
whole-genome sequencing in order to find rarer familial variants. A cost effective 
study approach would be through utilizing large population based cohorts that are 
currently being deep-sequenced, exome-sequenced or genotyped with GWA chips. 
Besides clinical and/or radiological data, applying known OA biomarker data from 
whole blood samples could yield interesting results. However, choosing reliable OA 
biomarkers might be a difficult task. However, on the other hand, their biological 
reliability would likely be higher than the symptom based clinical phenotype. 
Moreover, an expression study assessing the role of the four associated SNPs in the 
expression of IL1R1 gene itself, and other IL1 genes, would be useful. Detailed 
protein structure analyses of type IX collagen and MMP-8 for the different forms, 
according to the associated SNPs, would also gain important information about the 
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true biological meaning of these findings. Based on these results, the region of 
IL1R1 is currently undergoing deep sequencing in two pools of 8 and 10 individuals, 
selected based on their carrier status for the GG or GA genotype of the SNP 
rs2287047. 
 
When these projects were initiated, one hypotheses of OA was that the disease is 
caused by defective protein structure of the cartilage. Another point of view was that 
there is an imbalance between the cartilage break down and repair by chondrocytes. 
Additionally, based on disease mapping of different complex traits, it is now known 
that in addition to common variants predisposing to common diseases, it is likely 
that rare variants also contribute to common diseases, with rare variants being more 
likely to be functional than a common one (Zhu et al. 2011).  
 
With the newer technology it has been possible to perform studies without 
delimiting the study to a few a priori ideas and this will help OA research to a new 
level. Based on large GWA studies, it seems that both the immune system 
(Nakajima et al. 2010) and nerve growth (Day-Williams et al. 2011) are factors 
contributing to the disease. On the other hand, the role of chondrocytes is especially 
interesting in the development of OA. These cells are the only cells to maintain the 
cartilage, and while doing so they use the synovial fluid both as a source for 
nutrients and as a sewer system for metabolites (Corvol 2000). Another interesting 
view of OA relates it to obesity and cardiovascular diseases (Uchida et al. 2009). 
 
All in all, it has been known for decades that radiological OA changes and OA 
symptoms correlate relatively poorly. This speaks for the theory that both structural 
proteins of the joint in addition to the inflammatory system are involved. One can 
have degenerative changes without inflammation and painful symptoms. On the 
other hand, some individuals with very few radiological changes develop very 
painful symptoms in early stages. Cartilage breakdown products can trigger a pro-
inflammatory reaction (Monach et al. 2009) and immunological genes have been 
shown to associate with OA (Nakajima et al. 2010). This could indicate that some 
individuals have genetically the kind of host defense system that tends to react too 
keenly to cartilage breakdown particles and molecules. If this is the case, then also 
evolutionary this too keen immune system has probably had significant advantage 
in, for example, the defense against different microbial attacks. 
 
Finally, even with all the presented studies and results in this thesis work, scientists 
are still not even unanimous whether the disease progress initiates from the 
cartilage, bone or synovium. Even though we have come far since the earliest 
studies, we can still neither confirm nor discard the hypothesis of Bennett (1942), 
Collins (1947) and their co-workers who concluded that the OA changes initiate 
from the cartilage surface and proceed to deeper layers, causing later the changes to 
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the bone. We still need more systematic large gene mapping studies and large 
familial studies, combined with proteomics, lipidomics, and genome-wide 
expression profiling, for a better understanding of the disease. 
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